KINSUS — Annual Report 2025

Nov 7, 2025

English Translation of Financial Statements and a Report Originally Issued in Chinese

Ticker: 3189

Kinsus Interconnect Technology Corp. and Subsidiaries Consolidated Financial Statements With Review Report of Independent Auditors AS OF DECEMBER 31, 2025 AND 2024 And For The Years Then Ended

Address: No. 1245, Chung Hua Rd., Hsinwu District, Taoyuan City, Taiwan 32747 Telephone: (03) 487-1919

The reader is advised that these consolidated financial statements have been prepared originally in Chinese. In the event of a conflict between these financial statements and the original Chinese version or difference in interpretation between the two versions, the Chinese language financial statements shall prevail.

English Translation of Financial Statements and a Report Originally Issued in Chinese

Index Item	Page
1. Cover sheet	1
2. Index	2
3. Management representation letter	3
4. Independent Auditors' Report	4-8
5. Consolidated balance sheets	9-10
6. Consolidated statements of comprehensive income	11
7. Consolidated statements of changes in equity	12
8. Consolidated statements of cash flows	13
9. Footnotes to the consolidated financial statements
(1) History and organization	14
(2) Date and procedures of authorization of financial statements for issue	14
(3) Newly issued or revised standards and interpretations	14-20
(4) Summary of significant accounting policies	21-54
(5) Significant accounting judgments, estimates and assumptions	54-57
(6) Contents of significant accounts	57-108
(7) Related party transactions	109-113
(8) Assets pledged as collaterals	113
(9) Significant contingencies and unrecognized contract commitments	114
(10) Losses due to major disasters	114
(11) Significant subsequent events	115
(12) Others	115-126
(13) Additional disclosures
1. Information on significant transactions	126-127
2. Information on investees	127
3. Information on investments in Mainland China	128-133
(14) Operating segment	133-135

Consolidated Financial Statements

English Translation of Consolidated Financial Statements Originally Issued in Chinese Kinsus Interconnect Technology Corp. and Subsidiaries (Amounts Expressed In Thousands of New Taiwan Dollars) Consolidated Balance Sheets As of December 31, 2025 and 2024

	Assets			As of December 31, 2025	As of December 31, 2024
Code	Accounts	Notes	Amount	%	Amount	%
	Current assets
1100	Cash and cash equivalents	4, 6(1)	\$12,281,237	15	\$14,399,651	18
1110	Financial assets at fair value through profit or loss	4, 6(2)	1,410,294	2	1,121,378	1
1136	Financial assets measured at amortized cost	4, 6(3), 8	2,644,290	3	1,154,989	1
1150	Notes receivable, net	4, 6(5)	-	-	2,730	-
1170	Accounts receivable, net	4, 6(6)	6,802,761	9	5,281,641	7
1180	Accounts receivable - related parties, net	4, 6(6), 7	867	-	-	-
1200	Other receivables		97,074	-	34,584	-
1210	Other receivables from related parties	7	-	-	7,107	-
130x	Inventories, net	4, 6(7)	4,828,309	6	2,981,441	4
1410	Prepayments		552,934	1	885,568	1
1460	Disposal groups held for sale	4, 6(8)	-	-	3,603,466	5
1470	Other current assets		319,871	-	204,172	-
11xx	Total current assets		28,937,637	36	29,676,727	37
	Non-current assets
1517	Financial asset at fair value through OCI	4, 6(4)	52,727	-	51,000	-
1535	Financial assets measured at amortized cost	4, 6(3) ,8	37,107	-	-	-
1550	Investment accounted for using equity method	4, 6(9)	48,521	-	49,377	-
1600	Property, plant and equipment, net	4, 6(10), 7, 8, 9	41,936,711	53	36,408,840	47
1755	Right-of-use asset	4, 6(25)	568,815	1	370,874	-
1780	Intangible assets	4, 6(11)	175,270	-	53,317	-
1840	Deferred income tax assets	4, 6(28)	92,667	-	92,918	-
1900	Other non-current assets	6(12), 6(19),8	123,079	-	102,428	-
1915	Prepayment for acquiring machinery	6(10), 9	8,000,746	10	12,629,816	16
15xx	Total non-current assets		51,035,643	64	49,758,570	63
1xxx	Total Assets		\$79,973,280	100	\$79,435,297	100

English Translation of Consolidated Financial Statements Originally Issued in Chinese Kinsus Interconnect Technology Corp. and Subsidiaries Consolidated Balance Sheets-(Continued) As of December 31, 2025 and 2024 (Amounts Expressed In Thousands of New Taiwan Dollars)

	Liabilities and Equity		As of December 31, 2025		As of December 31, 2024
Code	Accounts	Notes	Amount	%	Amount	%
	Current liabilities
2100	Short-term loans	6(13)	\$3,053,498	4	\$2,451,503	3
2130	Contract liability	4, 6(23)	1,088,434	1	1,104,108	1
2150	Notes payable		71,041	-	46,166	-
2170	Accounts payable		3,828,757	5	2,453,573	3
2200	Other payables	6(14), 7	6,130,463	8	5,021,541	6
2230	Current income tax liabilities	4	1,139,648	1	913,316	1
2250	Provisions	4, 6(20)	24,312	-	-	-
2260	Liabilities directly associated with disposal groups held for sale	4, 6(8)	-	-	1,499,857	2
2280	Lease liability	4, 6(25)	38,155	-	31,533	-
2300	Other current liabilities	6(15)	4,339,228	6	3,173,872	5
2365	Refund liability	6(16)	392,880	-	294,908	-
21xx	Total current liabilities		20,106,416	25	16,990,377	21
	Non-current liabilities
2527	Contract liability	4, 6(23)	2,102,961	3	3,131,445	4
2540	Long-term loans	6(17), 8	11,197,127	14	13,779,184	18
2570	Deferred income tax liabilities	4, 6(28)	84,738	-	70,906	-
2580	Lease liability	4, 6(25)	77,794	-	73,586	-
2600	Other non-current liabilities	6(18), 7	5,031,047	6	5,511,566	7
25xx	Total non-current liabilities		18,493,667	23	22,566,687	29
2xxx	Total liabilities		38,600,083	48	39,557,064	50
31xx 3100	Equity attributable to shareholders of the parent Capital	6(21)
3110	Common stock		4,567,920	6	4,566,494	6
3200	Capital surplus	6(21)	7,375,477	9	7,357,577	9
3300	Retained earnings	6(21)
3310	Legal reserve		4,799,231	6	4,792,531	6
3320	Special reserve		45,148	-	195,240	-
3350	Unappropriated earnings		16,120,617	20	14,832,241	19
3400	Other components of equity		(176,628)	-	(91,788)	-
36xx	Non-controlling interests	6(21)	8,641,432	11	8,225,938	10
3xxx	Total equity		41,373,197	52	39,878,233	50
	Total liabilities and equity		\$79,973,280	100	\$79,435,297	100

English Translation of Consolidated Financial Statements Originally Issued in Chinese Kinsus Interconnect Technology Corp. and Subsidiaries Consolidated Statements of Comprehensive Income For the Years Ended December 31, 2025 and 2024 (Amounts Expressed in Thousands of New Taiwan Dollars, Except for Earnings per Share)

			2025		2024
Code	Items	Notes	Amount	%	Amount	%
4000	Operating revenues	4, 6(23), 7	\$39,351,096	100	\$30,534,979	100
5000	Operating costs	7	(31,036,687)	(79)	(21,867,254)	(72)
5900	Gross profit		8,314,409	21	8,667,725	28
6000	Operating expenses	7
	6100 Sales and marketing		(1,016,141)	(2)	(913,070)	(3)
	6200 General and administrative		(2,026,491)	(5)	(4,097,143)	(13)
	6300 Research and development		(2,609,820)	(7)	(2,611,654)	(9)
	6450 Expected credit gains (losses)	4, 6(24)	7,856	-	49,561	-
	Total operating expenses		(5,644,596)	(14)	(7,572,306)	(25)
6900	Operating income		2,669,813	7	1,095,419	3
7000	Non-operating incomes and expenses
	7100 Interest income	6(27)	385,608	1	530,300	2
	7010 Other incomes	6(27), 7	397,535	1	197,555	1
	7020 Other gains or losses	6(27)	26,523	-	169,200	-
	7050 Finance costs	6(27), 7	(391,418)	(1)	(394,341)	(1)
	7060 Share of the profit or loss of associates and joint ventures	6(9)	(856)	-	5,055	-
	Total non-operating incomes and expenses		417,392	1	507,769	2
7900	Income before income tax		3,087,205	8	1,603,188	5
7950	Income tax expense	4, 6(29)	(369,877)	(1)	(272,138)	(1)
8200	Net income		2,717,328	7	1,331,050	4
8300	Other comprehensive income	6(28)
8310	Item that not be reclassified to profit or loss
	8311 Actuarial gain (loss) from defined benefit plans		5,664	-	17,813	-
8316	Unrealized gain (loss) on equity instrument investment measured at fair value through other comprehensive income		(66,103)	-	-	-
8360	Items that may be reclassified subsequently to profit or loss
	8361 Exchange differences on translation of foreign operations		(133,683)	-	183,645	1
8399	Income tax related to items that may be reclassified to profit or loss		87	-	(52)	-
	Total other comprehensive income (loss), net of tax		(194,035)	-	201,406	1
8500	Total comprehensive income		\$2,523,293	7	\$1,532,456	5
8600	Net income attributable to:
	8610 Shareholders of the parent		\$1,595,936	4	\$48,889	-
	8620 Non-controlling interests		1,121,392	3	1,282,161	4
			\$2,717,328	7	\$1,331,050	4
8700	Comprehensive income attributable to:
	8710 Shareholders of the parent		\$1,494,391	4	\$216,794	1
	8720 Non-controlling interests		1,028,902	3	1,315,662	4
			\$2,523,293	7	\$1,532,456	5
9750	Earnings per share-basic (in NTD)	6(30)	\$3.51		\$0.11
9850	Earnings per share-diluted (in NTD)	6(30)	\$3.49		\$0.11

Kinsus Interconnect Technology Corp. and Subsidiaries

Consolidated Statements of Changes in Equity

For the Years Ended December 31, 2025 and 2024

(Amounts Expressed In Thousands of New Taiwan Dollars)

		Equity Attributable to Shareholders of the Parent
					Retained Earnings			Others
		Common Stock	Capital Surplus	Legal Reserve	Special Reserve	Unappropriated Earnings	Exchange differences arising on translation of foreign operations	Disposal groups held for sale	Unrealized gain(loss) on equity instrument investment measured at fair value through other comprehensive income	Unearned Employee Benefit	Total	Non-controlling Interests	Total Equity
Code	Items	3100	3200	3310	3320	3350	3410	3470	3490	3490	31XX	36XX	3XXX
	A1 Balance as of January 1, 2024	\$4,544,231	\$7,153,073	\$4,789,190	\$147,938	\$15,270,310	\$(195,240)	\$-	\$-	\$(14,613)	\$31,694,889	\$7,464,237	\$39,159,126
	Appropriation and distribution of 2023 earnings
	B1 Legal reserve			3,341		(3,341)					-		-
	B3 Special reserve				47,302	(47,302)					-		-
	B5 Cash dividends - ordinary shares					(454,423)					(454,423)		(454,423)
	C7 Changes in associates and joint ventures accounted for using the equity method		(7,298)								(7,298)	17	(7,281)
	D1 Net income for 2024					48,889					48,889	1,282,161	1,331,050
	D3 Other comprehensive income, net of tax, for 2024					17,813	150,092				167,905	33,501	201,406
	D5 Total comprehensive income	-	-	-	-	66,702	150,092	-	-	-	216,794	1,315,662	1,532,456
	O1 Non-controlling interests increase (decrease)											(553,978)	(553,978)
	T1 Disposal groups held for sale						45,148	(45,148)			-		-
	T1 Restricted employee stocks and others	22,263	211,802			295				(32,027)	202,333		202,333
	Z1 Balance as of December 31, 2024	4,566,494	7,357,577	4,792,531	195,240	14,832,241	-	(45,148)	-	(46,640)	31,652,295	8,225,938	39,878,233
	Appropriation and distribution of 2024 earnings
	B1 Legal reserve			6,700		(6,700)					-		-
	B5 Cash dividends - ordinary shares					(456,649)					(456,649)		(456,649)
	B17 Reversal of special reserve				(150,092)	150,092					-		-
	D1 Net income for 2025					1,595,936					1,595,936	1,121,392	2,717,328
	D3 Other comprehensive income, net of tax, for 2025					5,664	(107,978)	31,942	(31,173)		(101,545)	(92,490)	(194,035)
	D5 Total comprehensive income	-	-	-	-	1,601,600	(107,978)	31,942	(31,173)	-	1,494,391	1,028,902	2,523,293
	O1 Non-controlling interests increase (decrease)											(613,408)	(613,408)
	T1 Disposal groups held for sale						(13,206)	13,206
	T1 Restricted employee stocks and others	1,426	17,900			33				22,369	41,728	-	41,728
	Z1 Balance as of December 31, 2025	\$4,567,920	\$7,375,477	\$4,799,231	\$45,148	\$16,120,617	\$(121,184)	\$-	\$(31,173)	\$(24,271)	\$32,731,765	\$8,641,432	\$41,373,197

Kinsus Interconnect Technology Corp. and Subsidiaries Consolidated Statements of Cash Flows For the Years Ended December 31, 2025 and 2024 (Amounts Expressed in Thousands of New Taiwan Dollars)

Code	Items	2025	2024	Code	Items	2025	2024
AAAA	Cash flows from operating activities:			BBBB	Cash flows from investing activities:
A10000	Income before income tax	\$3,087,205	\$1,603,188	B00010	Acquisition of financial assets at fair value through other comprehensive	(67,830)	-
A20000	Adjustments:			B00040	Acquisition of financial assets at amortized cost	(1,526,408)	963,437
A20010	Income and expense adjustments:			B01900	Disposal of investments accounted for using the equity method	-	395,837
A20100	Depreciation (including right-of-use assets)	7,159,189	6,065,345	B02700	Acquisition of property, plant and equipment	(6,116,754)	(10,408,021)
A20200	Amortization	84,575	67,535	B02800	Proceeds from disposal of property, plant and equipment	110,221	119,202
A20300	Expected credit losses (gains)	(7,856)	(49,561)	B03800	Decrease in refundable deposits	(2,222)	19,063
A20400	Net gain of financial assets at fair value through P/L	(17,586)	(37,203)	B04500	Acquisition of intangible assets	(201,669)	(83,926)
A20900	Interest expense	391,418	394,341	B05350	Acquisition of right-of-use assets	(63,844)	(112,795)
A21200	Interest income	(385,608)	(530,300)	BBBB	Net cash provided by (used in) investing activities	(7,868,506)	(9,107,203)
A21900	Cost of share-based payment	41,124	72,498
A22300	Share of profit or loss of associates and joint ventures	856	(5,055)	CCCC	Cash flows from financing activities:
A22500	Loss (gain) on disposal of property, plant and equipment	28,734	(57,717)	C00100	Increase (decrease) in short-term loans	(289,016)	1,933,895
A23100	Gain on disposal of investments	(415)	-	C01600	Increase in long-term loans	1,755,000	1,577,369
A23200	Loss (gain) on disposal of investment accounted for using the equity method	-	(10,533)	C01700	Repayments of long-term loans	(3,186,156)	(1,887,641)
A23700	Impairment loss on non-financial assets	-	19,242	C03000	Increase (decrease) in deposits received	(451,736)	310,402
A29900	Gain on lease modification	(568)	(1,805)	C04020	Cash payments for the principal portion of the lease liability	(41,913)	(66,298)
A29900	Gain on government grants	(46,612)	(26,568)	C04500	Cash dividends paid	(456,649)	(454,423)
A30000	Changes in operating assets and liabilities:			C04600	Proceeds from issuing shares	13,200	136,671
A31115	Financial assets at fair value through profit or loss	(271,330)	2,110,049	C05800	Increase (decrease) in non-controlling interests	(613,408)	(553,978)
A31130	Notes receivable	2,730	2,030	C09900	Other financing activities	360	-
A31150	Accounts receivable	(1,513,260)	(938,330)	CCCC	Net cash provided by (used in) financing activities	(3,270,318)	995,997
A31160	Accounts receivable - related parties	(867)	367
A31180	Other receivables	(44,570)	34,001	DDDD	Effect of exchange rate changes	(38,577)	70,991
A31190 A31200	Other receivables-related parties Inventories	7,107 (1,499,097)	(7,107) (717,530)	EEEE	Increase (decrease) in cash and cash equivalents	(3,084,416)	(335,114)
A31230	Prepayments	363,961	119,733	E00100	Cash and cash equivalents at beginning of period	15,365,653	15,700,767
A31240	Other current assets	(25,930)	(26,427)	E00200	Cash and cash equivalents at end of period	\$12,281,237	\$15,365,653
A31990	Net defined benefit assets	(7,976)	(7,286)
A32125	Contract liabilities	(1,044,158)	(749,219)
A32130	Notes payable	24,875	(1,087)
A32150	Accounts payable	1,025,983	749,215
A32180	Other payables	768,403	(276,279)
A32200	Provisions	24,312	-
A32230	Other current liabilities	(28,646)	(513)
A32990	Refund liability	97,972	42,221	E00210	Cash and cash equivalents in the consolidated balance sheets	\$12,281,237	\$14,399,651
A32990	Other operating liability	-	8	E00212	Cash and cash equivalents in disposal groups held for sale	-	966,002
A33000	Cash generated from (used in) operations	8,213,965	7,837,253	E00200	Cash and cash equivalents in the consolidated statements of cash flows	\$12,281,237	\$15,365,653
A33100	Interest received	385,483	586,620
A33300	Interest paid	(366,608)	(359,702)
A33500	Income tax paid	(139,855)	(359,070)
AAAA	Net cash provided by (used in) operating activities	8,092,985	7,705,101

English Translation of Consolidated Financial Statements and Footnotes Originally Issued in Chinese Kinsus Interconnect Technology Corp. Notes to the Consolidated Financial Statements (Amounts Expressed in Thousands of New Taiwan Dollars unless Otherwise Specified)

1. HISTORY AND ORGANIZATION

Kinsus Interconnect Technology Corp. (referred to "the Company") was established on September 11, 2000. Its main business activities include the manufacture of electronic products, the whole-sale and retail-sale of electronic materials, and the consultation services of business operation and management. The Company's stocks were approved on May 20, 2004 to be listed and traded in Taiwan Stock Exchange starting November 1, 2004. The registered business premise and main operation address is at No. 1245, Chung Hua Rd., Hsinwu District, Taoyuan City, Taiwan 32747.

Pegatron Corporation is the ultimate controller of the Group to which the Company belongs.

2. DATE AND PROCEDURE OF AUTHORIZATION FOR FINANCIAL STATEMENTS ISSUANCE

The consolidated financial statements of the Company and its subsidiaries ("the Group") were authorized to be issued in accordance with a resolution of the Board of Directors' meeting held on January 30, 2026.

3. NEWLY ISSUED OR REVISED STANDARDS AND INTERPRETATIONS

(1) Changes in accounting policies resulting from applying for the first time certain standards and amendments

The Group applied for the first time International Financial Reporting Standards, International Accounting Standards, and Interpretations issued, revised, or amended which are recognized by the Financial Supervisory Commission ("FSC") and become effective for annual periods beginning on or after January 1, 2025. The adoption of these new standards and amendments had no material impact on the Group.

(2) Standards or interpretations issued, revised or amended, by International Accounting Standards Board ("IASB") which have been endorsed by FSC, and not yet adopted by the Group as at the date when the Group's financial statements were authorized for issue, are listed below.

		Effective Date issued
Items	New, Revised or Amended Standards and Interpretations	by IASB
a	IFRS 17 "Insurance Contracts"	January 1 , 2023
b	Amendments to the Classification and Measurement of	January 1 , 2026
	Financial Instruments – Amendments to IFRS 9 and IFRS 7
c	Annual Improvements to IFRS Accounting Standards –	January 1 , 2026
	Volume 11
d	Contracts Referencing Nature-dependent Electricity –	January 1 , 2026
	Amendments to IFRS 9 and IFRS 7

A.IFRS 17 "Insurance Contracts"

IFRS 17 provides a comprehensive model for insurance contracts, covering all relevant accounting aspects (including recognition, measurement, presentation and disclosure requirements). The core of IFRS 17 is the General (building block) Model, under this model, on initial recognition, an entity shall measure a group of insurance contracts at the total of the fulfilment cash flows and the contractual service margin. The carrying amount of a group of insurance contracts at the end of each reporting period shall be the sum of the liability for remaining coverage and the liability for incurred claims.

Other than the General Model, the standard also provides a specific adaptation for contracts with direct participation features (the Variable Fee Approach) and a simplified approach (Premium Allocation Approach) mainly for short-duration contracts.

IFRS 17 was issued in May 2017 and it was amended in 2020 and 2021. The amendments include deferral of the date of initial application of IFRS 17 by two years to annual beginning on or after January 1 , 2023 (from the original effective date of January 1 , 2021); provide additional transition reliefs; simplify some requirements to reduce the costs of applying IFRS 17 and revise some requirements to make the results easier to explain. IFRS 17 replaces an interim Standard – IFRS 4 Insurance Contracts – from annual reporting periods beginning on or after January 1 , 2023.

B.Amendments to the Classification and Measurement of Financial Instruments – Amendments to IFRS 9 and IFRS 7

The amendments include:

• a.Clarify that a financial liability is derecognised on the settlement date and describe the accounting treatment for settlement of financial liabilities using an electronic payment system before the settlement date.
• b.Clarify how to assess the contractual cash flow characteristics of financial assets that include environmental, social and governance (ESG)-linked features and other similar contingent features.
• c.Clarify the treatment of non-recourse assets and contractually linked instruments.
• d.Require additional disclosures in IFRS 7 for financial assets and liabilities with contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value through other comprehensive income.
• C.Annual Improvements to IFRS Accounting Standards Volume 11

a.Amendments to IFRS 1

The amendments mainly improve the consistency in wording between first-time adoption of IFRS and requirements for hedge accounting in IFRS 9.

b.Amendments to IFRS 7

The amendments update an obsolete cross-reference relating to gain or loss on derecognition.

c.Amendments to Guidance on implementing IFRS 7

The amendments improve some of the wordings in the implementation guidance, including the introduction, disclosure of deferred difference between fair value and transaction price and credit risk disclosures.

d.Amendments to IFRS 9

The amendments add a cross-reference to resolve potential confusion for a lessee applying the derecognition requirements and clarify the term "transaction price".

e.Amendments to IFRS 10

The amendments remove the inconsistency between paragraphs B73 and B74 of IFRS

f.Amendments to IAS 7

The amendments remove a reference to "cost method" in paragraph 37 of IAS 7.

D.Contracts Referencing Nature-dependent Electricity – Amendments to IFRS 9 and IFRS 7

The amendments include:

a.Clarify the application of the 'own-use' requirements.

b.Permit hedge accounting if these contracts are used as hedging instruments.

c.Add new disclosure requirements to enable investors to understand the effect of these contracts on a company's financial performance and cash flows.

The above mentioned standards and amendments are applicable for annual periods beginning on or after January 1, 2026 and have no material impact on the Group.

(3)Standards or interpretations issued, revised or amended, by IASB which have not been endorsed by FSC, and not yet adopted by the Group as at the date when the Group's financial statements were authorized for issue, are listed below.

		Effective Date
Items	New, Revised or Amended Standards and Interpretations	issued by IASB
a	IFRS 10 "Consolidated Financial Statements" and IAS 28	To be
	"Investments in Associates and Joint Ventures" – Sale or	determined by
	Contribution of Assets between an Investor and its Associate or	IASB
	Joint Ventures
b	IFRS 18 "Presentation and Disclosure in Financial Statements" January 1, 2027
		(Note)
c	Disclosure Initiative – Subsidiaries without Public	January 1, 2027
	Accountability: Disclosures (IFRS 19)
d	Translation to a Hyperinflationary Presentation Currency	January 1, 2027
	(Amendments to IAS 21 and IAS 29)

• Note: On 25 September 2025, the FSC announced in a press release that Taiwan will adopt IFRS 18 in 2028.
• A.IFRS 10 "Consolidated Financial Statements" and IAS 28"Investments in Associates and Joint Ventures" — Sale or Contribution of Assets between an Investor and its Associate or Joint Ventures

The amendments address the inconsistency between the requirements in IFRS 10 Consolidated Financial Statements and IAS 28 Investments in Associates and Joint Ventures, in dealing with the loss of control of a subsidiary that is contributed to an associate or a joint venture. IAS 28 restricts gains and losses arising from contributions of non-monetary assets to an associate or a joint venture to the extent of the interest attributable to the other equity holders in the associate or joint ventures. IFRS 10 requires full profit or loss recognition on the loss of control of the subsidiary. IAS 28 was amended so that the gain or loss resulting from the sale or contribution of assets that constitute a business as defined in IFRS 3 between an investor and its associate or joint venture is recognized in full.

IFRS 10 was also amended so that the gains or loss resulting from the sale or contribution of a subsidiary that does not constitute a business as defined in IFRS 3 between an investor and its associate or joint venture is recognized only to the extent of the unrelated investors' interests in the associate or joint venture.

B.IFRS 18 "Presentation and Disclosure in Financial Statements"

IFRS 18 replaces IAS 1 Presentation of Financial Statements. The main changes are as below:

a.Improved comparability in the statement of profit or loss (income statement)

IFRS 18 requires entities to classify all income and expenses within their statement of profit or loss into one of five categories: operating; investing; financing; income taxes; and discontinued operations. The first three categories are new, to improve the structure of the income statement, and requires all entities to provide new defined subtotals, including operating profit or loss. The improved structure and new subtotals will give investors a consistent starting point for analyzing entities' performance and make it easier to compare entities.

b.Enhanced transparency of management-defined performance measures

IFRS 18 requires entities to disclose explanations of those entity-specific measures that are related to the income statement, referred to as management-defined performance measures.

c.Useful grouping of information in the financial statements

IFRS 18 sets out enhanced guidance on how to organize information and whether to provide it in the primary financial statements or in the notes. The changes are expected to provide more detailed and useful information. IFRS 18 also requires entities to provide more transparency about operating expenses, helping investors to find and understand the information they need.

C.Disclosure Initiative – Subsidiaries without Public Accountability: Disclosures (IFRS 19)

This new standard and its amendments permit subsidiaries without public accountability to provide reduced disclosures when applying IFRS Accounting Standards in their financial statements. IFRS 19 is optional for subsidiaries that are eligible and sets out the disclosure requirements for subsidiaries that elect to apply it.

D.Translation to a Hyperinflationary Presentation Currency (Amendments to IAS 21 and IAS 29)

The amendments include:

• a.Clarify that when the entity's functional currency is that of a non hyperinflationary economy but its presentation currency is the currency of a hyperinflationary economy, the entity shall translate its results and financial position using the closing rate at the date of the most recent statement of financial position.
• b.In the above circumstances, when the presentation currency ceases to be hyperinflationary economy, the entity shall not retranslate amounts that arose before the beginning of the reporting period.
• c.When the entity's functional currency and presentation currency are the currency of a hyperinflationary economy, the entity shall apply the relevant accounting treatment in accordance with paragraph 34 of IAS 29.

The above mentioned standards and interpretations issued by IASB have not yet endorsed by FSC at the date when the Group's financial statements were authorized for issue, the local effective dates are to be determined by FSC. As the Group is still currently determining the potential impact of the new or amended standards and interpretations listed under (B), it is not practicable to estimate their impact on the Group at this point in time. The remaining new or amended standards and interpretations have no material impact on the Group.

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(1) Statement of compliance

The consolidated financial statements of the Group for the years ended December 31, 2025 and 2024 were prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers ("the Regulations") and International Financial Reporting Standards, International Accounting Standards, and Interpretations developed by the International Financial Reporting Interpretations Committee or the former Standing Interpretations Committee as endorsed by the FSC.

(2) Basis of preparation

The consolidated financial statements have been prepared on a historical cost basis, except for financial instruments that have been measured at fair value. The consolidated financial statements are expressed in thousands of New Taiwan Dollars ("NT\$") unless otherwise stated.

(3) Basis of consolidation

Preparation principle of consolidated financial statements

Control is achieved when the Company is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. Specifically, the Company controls an investee if and only if the Company has:

• (a) Power over the investee (i.e. existing rights that give it the current ability to direct the relevant activities of the investee)
• (b) Exposure, or rights, to variable returns from its involvement with the investee, and
• (c) The ability to use its power over the investee to affect its returns

When the Company has less than a majority of the voting or similar rights of an investee, the Company considers all relevant facts and circumstances in assessing whether it has power over an investee, including:

• (a) The contractual arrangement with the other vote holders of the investee
• (b) Rights arising from other contractual arrangements
• (c) The Company's voting rights and potential voting rights

The Company re-assesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the three elements of control.

Subsidiaries are fully consolidated from the acquisition date, being the date on which the Company obtains control, and continue to be consolidated until the date that such control ceases. The financial statements of the subsidiaries are prepared for the same reporting period as the parent company, using uniform accounting policies. All intra-group balances, income and expenses, unrealized gains and losses and dividends resulting from intra-group transactions are eliminated in full.

A change in the ownership interest of a subsidiary, without a change of control, is accounted for as an equity transaction.

Total comprehensive income of the subsidiaries is attributed to the owners of the parent and to the NCIs even if this results in a deficit balance of the NCIs.

If the Company loses control of a subsidiary, it:

• (a) Derecognizes the assets (including goodwill) and liabilities of the subsidiary;
• (b) Derecognizes the carrying amount of any non-controlling interest;
• (c) Recognizes the fair value of the consideration received;
• (d) Recognizes the fair value of any investment retained;
• (e) Reclassifies the parent's share of components previously recognized in other comprehensive income to profit or loss, or directly transferred to retained earnings in accordance with other IFRS requirements; and
• (f) Recognizes the difference arise in profit or loss for the period.

The consolidated entities are listed as follows:

			Percentage of Ownership	(%),
			As of December 31,
Investor	Subsidiary	Main business	2025	2024
The Company	KINSUS CORP. (USA)	Designing substrates, formulating marketing strategy analysis, developing new customers, researching and development new product technology	100.00%	100.00%
The Company	KINSUS HOLDING (SAMOA) LIMITED	Investing activities	100.00%	100.00%
The Company	KINSUS INVESTMENT CO., LTD.	Investing activities	100.00%	100.00%
The Company	PEGAVISION CORPORATION	Manufacture of medical equipment	2.33% (Note)	2.33% (Note)
KINSUS HOLDING (SAMOA) LIMITED	KINSUS HOLDING (CAYMAN) LIMITED	Investing activities	100.00%	100.00%
KINSUS HOLDING (SAMOA) LIMITED	PIOTEK HOLDINGS LTD. (CAYMAN)	Investing activities	51.00% (Note 2)	51.00% (Note 2)
KINSUS INVESTMENT CO., LTD.	PEGAVISION CORPORATION	Manufacture of medical equipment	27.22% (Note)	27.22% (Note)

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

			Percentage of Ownership As of	(%), December 31,
Investor	Subsidiary	Main business	2025	2024
KINSUS HOLDING (CAYMAN) LIMITED	KINSUS INTERCONNECT TECHNOLOGY SUZHOU CORP.	Manufacturing and selling printed circuit board (PCB) (not high density fine-line)	100.00%	100.00%
PIOTEK HOLDINGS LTD. (CAYMAN)	PIOTEK HOLDING LIMITED	Investing activities	100.00%	100.00%
PIOTEK HOLDINGS LIMITED	PIOTEK COMPUTER (SUZHOU) CO., LTD.	Researching, developing, producing and selling electronic components, PCBs and related products and providing after-sale services	83.06% (Note 2)	83.06% (Note 2)
PIOTEK HOLDINGS LIMITED	PIOTEK (H.K.) TRADING LIMITED	Trading activities	-% (Note3)	100.00%
KINSUS INTERCONNECT TECHNOLOGY SUZHOU CORP.	PIOTEK COMPUTER (SUZHOU) CO., LTD.	Researching, developing, producing and selling electronic components, PCBs and related products and providing after-sale services	8.64% (Note 2)	8.64% (Note 2)
PEGAVISION CORPORATION	PEGAVISION JAPAN INC.	Selling medical equipment	100.00%	100.00%
PEGAVISION CORPORATION	PEGAVISION (JIANGSU) LIMITED	Producing and selling medical equipment	100.00%	100.00%

			Percentage of Ownership As of	(%), December 31,
Investor	Subsidiary	Main business	2025	2024
PEGAVISION CORPORATION	MAYIN INVESTMENT CO., LTD.	Investing activities	100.00%	100.00%
PEGAVISION CORPORATION	PEGAVISION VIETNAM COMPANY LIMITED	Manufacturing and selling medical equipment	100.00%	100.00%
PEGAVISION CORPORATION	PEGAVISION (SHANGHAI) LIMITED	Selling medical equipment	100.00% (Note 1)	100.00% (Note 1)
PEGAVISION CORPORATION	PEGAVISION NETHERLAND SB.V.	Selling medical equipment	100.00% (Note 4)	Not applicable
MAYIN INVESTMENT CO., LTD.	BeautyTech Platform Corporation	Selling medical equipment and cosmetic products	85.00%	85.00%
MAYIN INVESTMENT CO., LTD.	FACIALBEAU INTERNATIONAL CORPORATION	Selling medical equipment and cosmetic products	55.00%	55.00%
BeautyTech Platform Corporation	PEGAVISION (SHANGHAI) LIMITED	Selling medical equipment	-% (Note5)	100.00%
BeautyTech Platform Corporation	BeautyTech Platform (Shanghai) Corporation	Selling medical equipment and cosmetic products	100.00% (Note5)	100.00%

			Percentage of Ownership As of	(%), December 31,
Investor	Subsidiary	Main business	2025	2024
BeautyTech Platform Corporation	Beautytech Platform (Singapore) Pte. Ltd.	Selling medical equipment and cosmetic products	-% (Note6)	100.00%
BeautyTech Platform Corporation	FORIMART Corporation	Selling medical equipment and cosmetic products	100.00%	100.00%
BeautyTech Platform Corporation	BEAUTYTECH PLATFORM (VIETNAM) LIMITED LIABILITY COMPANY	Selling medical equipment and cosmetic products	70.00%	70.00%
PEGAVISION (SHANGHAI) LIMITED	GEMVISION TECHNOLOGY (ZHEJIANG) LIMITED	Selling medical equipment and cosmetic products	-% (Note5)	100.00%
BeautyTech Platform (Shanghai) Corporation	Gemvision Technology (Zhejiang) Limited	Selling medical equipment and cosmetic products	100.00% (Note5)	Not applicable
FACIALBEAU INTERNATIONAL CORPORATION	FACIALBEAU (JIANGSU) CORPORATION	Selling medical equipment and cosmetic products	100.00% (Note 1)	100.00% (Note 1)
FACIALBEAU INTERNATIONAL CORPORATION	IKIDO INC.	Selling medical equipment and cosmetic products	100.00%	100.00%

Notes to Consolidated Financial Statements (Continued)

			Percentage of Ownership As of	(%), December 31,
Investor	Subsidiary	Main business	2025	2024
FACIALBEAU INTERNATIONAL CORPORATION	RODNA CO., LTD.	Selling medical equipment and cosmetic products	100.00%	100.00%
FACIALBEAU INTERNATIONAL CORPORATION	AQUAMAX VISION CORPORATION	Selling medical equipment and cosmetic products	100.00%	100.00%

• Note: As of December 31, 2025 and 2024, the Group had 29.55% ownership of Pegavision Corporation, respectively. However, the Group possesses control over the entity as it has been the single largest shareholder since the Group invested in Pegavision Corporation. The Group and the parent company hold more than 45% of voting right while the remaining equity is individually held by numerous shareholders without contractual rights. The Group therefore has control over the entity.
• Note 1: To improve the synergy of the Group, the board of directors decided to reorganize and set up the Subsidiaries on July 26, 2021:
• (a) Facial Beau (Jiangsu) Corporation which is 100% held by FacialBeau International Corporation was registered on February 25, 2022. The investment amount has not been remitted as of December 31, 2025.
• (b) PEGAVISION (SHANGHAI) LIMITED which is 100% held by PEGAVISION CORPORATION was registered on April 23, 2024. The investment amount has not been remitted as of December 31, 2025.

• Note 2: The Company's subsidiary, Piotek Computer (Suzhou) Co., Ltd., conducted a cash capital increase in September 2023. The Company's subsidiary, Piotek Holding Limited, did not participate in the cash capital increase, and its ownership percentage decreased from 100.00% to 83.06%. Instead, the Company's subsidiary, Kinsus Interconnect Technology Suzhou Corp, participated in the cash capital increase and its ownership percentage after the capital increase was 8.64%. However, the Company's subsidiary, Kinsus Holding (Samoa) Limited, maintained an ultimate consolidated ownership percentage of 51%.

• Note3: PIOTEK(H.K.) TRADING LIMITED have completed the deregistration on 27 February 2025.

• Note4: To develop the European market, the board of directors resolved on December 31, 2024 to set up PEGAVISION NETHERLANDS B.V., which was 100% directy held by the company. The registration was completed on February 28, 2025.
• Note5: As part of the Group's business reorganization, BEAUTYTECH PLATFORM (SHANGHAI) CORPORATION has merged with PEGAVISION (SHANGHAI) LIMITED in 2025. BEAUTYTECH PLATFORM (SHANGHAI) CORPORATION is the surviving entity, and PEGAVISION (SHANGHAI) LIMITED was dissolved upon the completion of the merger.
• Note6: BEAUTYTECH PLATFORM (SINGAPORE) PTE. LCD. Has completed the cancellation of registration in 2025 due to group business adjustments.
• (4) Foreign currency transactions

The Group's consolidated financial statements are presented in New Taiwan Dollar, which is the parent company's functional currency. Each entity in the Group determines its own functional currency and items included in the financial statements of each entity are measured using that functional currency.

Transactions in foreign currencies are initially recorded by the Group entities at their respective functional currency rates prevailing at the date of the transaction. At the reporting date, monetary items denominated in foreign currencies are retranslated at the prevailing functional currency closing rate of exchange; non-monetary items measured at fair value in a foreign currency are retranslated using the exchange rates at the date when the fair value is determined; and non-monetary items measured at historical cost in a foreign currency are translated using the exchange rates as at the dates of the initial transactions.

All exchange differences arising from the settlement or translation of monetary items are taken to profit or loss in the period in which they arise, except for the following:

(a) Exchange differences arising from foreign currency borrowings for an acquisition of a qualifying asset to the extent that they are regarded as an adjustment to interest costs are included in the borrowing costs that are eligible for capitalization.

• (b) Foreign currency items within the scope of IFRS 9 Financial Instruments are accounted for based on the accounting policy for financial instruments.
• (c) Exchange differences arising on a monetary item that forms part of a reporting entity's net investment in a foreign operation is recognized initially in other comprehensive income and reclassified from equity to profit or loss on disposal of the net investment.

When a gain or loss on a non-monetary item is recognized in other comprehensive income, any exchange component of that gain or loss is recognized in other comprehensive income. When a gain or loss on a non-monetary item is recognized in profit or loss, any exchange component of that gain or loss is recognized in profit or loss.

(5) Foreign currency transactions and translation of financial statements in foreign currency

The assets and liabilities of foreign operations are translated into New Taiwan dollars at the closing rate of exchange prevailing at the balance sheet date and their income and expenses are translated at an average rate for the period. The exchange differences arising on the translation are recognized in other comprehensive income under exchange differences on translation of foreign operations. On disposal of the foreign operation, cumulative amount of the exchange differences recognized in other comprehensive income under separate component of equity is reclassified from equity to profit or loss when recognizing the disposal gain/loss.

On the partial disposal of a subsidiary that includes a foreign operation that does not result in a loss of control, the proportionate share of the cumulative amount of the exchange differences recognized in other comprehensive income is re-attributed to the non-controlling interests in that foreign operation, instead of being recognized in profit or loss. In partial disposal of an associate or jointly controlled entity that includes a foreign operation that does not result in a loss of significant influence or joint control, only the proportionate share of the cumulative amount of the exchange differences recognized in other comprehensive income is reclassified to profit or loss.

Any goodwill and fair value adjustments to the carrying amounts of assets and liabilities arising on the acquisition of a foreign operation are treated as assets and liabilities of the foreign operation and expressed in its functional currency.

(6) Current and non-current distinction for assets and liabilities

An asset is classified as current when:

• (a) The Group expects to realize the asset, or intends to sell or consume it, in its normal operating cycle.
• (b) The Group holds the asset primarily for the purpose of trading.
• (c) The Group expects to realize the asset within twelve months after the reporting period.
• (d) The asset is cash or cash equivalent, unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.

All other assets are classified as non-current.

A liability is classified as current when:

• (a) The Group expects to settle the liability in its normal operating cycle.
• (b) The Group holds the liability primarily for the purpose of trading.
• (c) The liability is due to be settled within twelve months after the reporting period.
• (d) The Group does not have the right at the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period.

All other liabilities are classified as non-current.

(7) Cash and cash equivalents

Cash and cash equivalents comprise cash on hand, demand deposits and short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value (including fixed-term deposits that have maturities equal to or less than three months from the date of acquisition).

(8) Financial instruments

Financial assets and financial liabilities are recognized when the Group becomes a party to the contractual provisions of the instrument.

Financial assets and financial liabilities within the scope of IFRS 9 Financial Instruments are recognized initially at fair value plus or minus, in the case of investments not at fair value through profit or loss, directly attributable transaction costs.

(a) Financial assets: Recognition and Measurement

The Group accounts for regular way purchase or sales of financial assets on the trade date.

The Group classified financial assets as subsequently measured at amortized cost, fair value through other comprehensive income or fair value through profit or loss considering both factors below:

A. The Group's business model for managing the financial assets and

B. The contractual cash flow characteristics of the financial asset.

Financial assets measured at amortized cost

A financial asset is measured at amortized cost if both of the following conditions are met and presented as note receivables, trade receivables financial assets measured at amortized cost and other receivables etc., on balance sheet as at the reporting date:

• A. The financial asset is held within a business model whose objective is to hold financial assets in order to collect contractual cash flows and
• B. The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

Such financial assets are subsequently measured at amortized cost (the amount at which the financial asset is measured at initial recognition minus the principal repayments, plus or minus the cumulative amortization using the effective interest method of any difference between the initial amount and the maturity amount and adjusted for any loss allowance) and is not part of a hedging relationship. A gain or loss is recognized in profit or loss when the financial asset is derecognized, through the amortization process or in order to recognize the impairment gains or losses.

Interest revenue is calculated by using the effective interest method. This is calculated by applying the effective interest rate to the gross carrying amount of a financial asset except for:

• A. Purchased or originated credit-impaired financial assets. For those financial assets, the Group applies the credit-adjusted effective interest rate to the amortized cost of the financial asset from initial recognition.
• B. Financial assets that are not purchased or originated credit-impaired financial assets but subsequently have become credit-impaired financial assets. For those financial assets, the Group applies the effective interest rate to the amortized cost of the financial asset in subsequent reporting periods.

Financial asset measured at fair value through other comprehensive income

A financial asset is measured at fair value through other comprehensive income if both of the following conditions are met:

• A. The financial asset is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets and
• B. The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

Recognition of gain or loss on a financial asset measured at fair value through other comprehensive income are described as below:

• A. A gain or loss on a financial asset measured at fair value through other comprehensive income recognized in other comprehensive income, except for impairment gains or losses and foreign exchange gains and losses, until the financial asset is derecognized or reclassified.

• B. When the financial asset is derecognized the cumulative gain or loss previously recognized in other comprehensive income is reclassified from equity to profit or loss as a reclassification adjustment.

• C. Interest revenue is calculated by using the effective interest method. This is calculated by applying the effective interest rate to the gross carrying amount of a financial asset except for:

• (i) Purchased or originated credit-impaired financial assets. For those financial assets, the Group applies the credit-adjusted effective interest rate to the amortized cost of the financial asset from initial recognition.
• (ii) Financial assets that are not purchased or originated credit-impaired financial assets but subsequently have become credit-impaired financial assets. For those financial assets, the Group applies the effective interest rate to the amortized cost of the financial asset in subsequent reporting periods.

Additionally, at initial recognition, the Group make an irrevocable election to present in other comprehensive income subsequent changes in the fair value of an investment in an equity instrument within the scope of IFRS 9 that is neither held for trading nor contingent consideration recognized by an acquirer in a business combination to which IFRS 3 applies. Amounts presented in other comprehensive income are not subsequently transferred to profit or loss (when disposal of such equity instrument, its cumulated amount included in other components of equity is transferred directly to the retained earnings) and should recorded as financial assets measured at fair value through other comprehensive income on balance sheet. Dividends on such investment are recognized in profit or loss unless the dividends clearly represents a recovery of part of the cost of investment.

Financial asset measured at fair value through profit or loss

Financial assets were measured at amortized cost or measured at fair value through other comprehensive income only if they met particular conditions. All other financial assets were measured at fair value through profit or loss and presented on the balance sheet as financial assets measured at fair value through profit or loss.

Such financial assets are measured at fair value, the gains or losses resulting from remeasurement is recognized in profit or loss which includes any dividend or interest received on such financial assets.

(b) Impairment of financial assets

The Group recognizes a loss allowance for expected credit losses on debt instrument investments measured at fair value through other comprehensive income and financial asset measured at amortized cost. The loss allowance on debt instrument investments measured at fair value through other comprehensive income is recognized in other comprehensive income and not reduce the carrying amount in the statement of financial position.

The Group measures expected credit losses of a financial instrument in a way that reflects:

• A. An unbiased and probability-weighted amount that is determined by evaluating a range of possible outcomes;
• B. The time value of money; and
• C. Reasonable and supportable information that is available without undue cost or effort at the reporting date about past events, current conditions and forecasts of future economic conditions.

The loss allowance is measures as follows:

• A. At an amount equal to 12-month expected credit losses: the credit risk on a financial asset has not increased significantly since initial recognition or the financial asset is determined to have low credit risk at the reporting date. In addition, the Group measures the loss allowance for a financial asset at an amount equal to lifetime expected credit losses in the previous reporting period, but determines at the current reporting date that condition is no longer met.
• B. At an amount equal to the lifetime expected credit losses: the credit risk on a financial asset has increased significantly since initial recognition or financial asset that is purchased or originated credit-impaired financial asset.
• C. For trade receivables or contract assets arising from transactions within the scope of IFRS 15, the Group measures the loss allowance at an amount equal to lifetime expected credit losses.

D. For lease receivables arising from transactions within the scope of IFRS 16, the Group measures the loss allowance at an amount equal to lifetime expected credit losses.

At each reporting date, the Group needs to assess whether the credit risk on a financial asset has been increased significantly since initial recognition by comparing the risk of a default occurring at the reporting date and the risk of default occurring at initial recognition. Please refer to Note 12 for further details on credit risk.

(c) Derecognition of financial assets

A financial asset is derecognized when:

• A. The rights to receive cash flows from the asset have expired.
• B. The Group has transferred the asset and substantially all the risks and rewards of the asset have been transferred.
• C. The Group has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.

On derecognition of a financial asset in its entirety, the difference between the carrying amount and the consideration received or receivable including any cumulative gain or loss that had been recognized in other comprehensive income, is recognized in profit or loss.

(d) Financial liabilities and equity

Classification between liabilities or equity

The Group classifies the instrument issued as a financial liability or an equity instrument in accordance with the substance of the contractual arrangement and the definitions of a financial liability, and an equity instrument.

Equity instruments

An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. The transaction costs of an equity transaction are accounted for as a deduction from equity (net of any related income tax benefit) to the extent they are incremental costs directly attributable to the equity transaction that otherwise would have been avoided.

Financial liabilities

Financial liabilities within the scope of IFRS 9 Financial Instruments are classified as financial liabilities at fair value through profit or loss or financial liabilities measured at amortized cost upon initial recognition.

Financial liabilities at fair value through profit or loss

Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated as at fair value through profit or loss. A financial liability is classified as held for trading if:

• A. It is acquired or incurred principally for the purpose of selling or repurchasing it in the near term;
• B. On initial recognition it is part of a portfolio of identified financial instruments that are managed together and for which there is evidence of a recent actual pattern of short-term profit-taking; or
• C. It is a derivative (except for a derivative that is a financial guarantee contract or a designated and effective hedging instrument).

If a contract contains one or more embedded derivatives, the entire hybrid (combined) contract may be designated as a financial liability at fair value through profit or loss; or a financial liability may be designated as at fair value through profit or loss when doing so results in more relevant information, because either:

• A. It eliminates or significantly reduces a measurement or recognition inconsistency; or
• B. A group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the key management personnel.

Gains or losses on the subsequent measurement of liabilities at fair value through profit or loss including interest paid are recognized in profit or loss.

Financial liabilities at amortized cost

Financial liabilities measured at amortized cost include interest bearing loans and borrowings that are subsequently measured using the effective interest rate method after initial recognition. Gains and losses are recognized in profit or loss when the liabilities are derecognized as well as through the effective interest rate method amortization process.

Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or transaction costs.

Derecognition of financial liabilities

A financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.

When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified (whether or not attributable to the financial difficulty of the debtor), such an exchange or modification is treated as a derecognition of the original liability and the recognition of a new liability, and the difference in the respective carrying amounts and the consideration paid, including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

(e) Offsetting of financial instruments

Financial assets and financial liabilities are offset and the net amount reported in the balance sheet if, and only if, there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, or to realize the assets and settle the liabilities simultaneously.

(9) Fair value measurement

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

• (a) In the principal market for the asset or liability, or
• (b) In the absence of a principal market, in the most advantageous market for the asset or liability

The principal or the most advantageous market must be accessible to by the Group.

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants in their economic best interest.

A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

(10)Inventories

Inventories are valued at lower of cost or net realizable value item by item.

Costs incurred in bringing each inventory to its present location and conditions are accounted for as follows:

Raw materials - At actual purchase cost, using weighted average method Finished goods and work in progress - Including cost of direct materials and labor and a proportion of manufacturing overheads based on normal operating capacity, using weighted average method.

Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.

Rendering of services is accounted in accordance with IFRS 15 but not within the scoping of inventories.

(11)Non-current assets held for sale and discontinued operations

Non-current assets and disposal groups are classified as held for sale if their carrying amounts will be recovered through a sale transaction that is highly probable within one year from the date of classification and the asset or disposal group is available for immediate sale in its present condition. Non-current assets and disposal groups classified as held for sale are measured at the lower of their carrying amount and fair value less costs to sell.

In the consolidated statement of comprehensive income of the reporting period, and of thecomparable period of the previous year, income and expenses from discontinued operations are reported separately from income and expenses from continuing operations, down to the level of profit after taxes, even when the Company retains a non-controlling interest in the subsidiary after the sale. The resulting profit or loss (after taxes) is reported separately in the statement of comprehensive income.

Property, plant and equipment and intangible assets once classified as held for sale are not depreciated or amortized.

(12)Investments accounted for using the equity method

The Group's investment in its associate is accounted for using the equity method other than those that meet the criteria to be classified as held for sale. An associate is an entity over which the Group has significant influence. A joint venture is a type of joint arrangement whereby the parties that have joint control of the arrangement have rights to the net assets of the joint venture.

Under the equity method, the investment in the associate or an investment in a joint venture is carried in the balance sheet at cost and adjusted thereafter for the post-acquisition change in the Group's share of net assets of the associate or joint venture. After the interest in the associate or joint venture is reduced to zero, additional losses are provided for, and a liability is recognized, only to the extent that the Group has incurred legal or constructive obligations or made payments on behalf of the associate or joint venture. Unrealized gains and losses resulting from transactions between the Group and the associate or joint venture are eliminated to the extent of the Group's related interest in the associate or joint venture.

When changes in the net assets of an associate or a joint venture occur and not those that are recognized in profit or loss or other comprehensive income and do not affect the Group's percentage of ownership interests in the associate or joint venture, the Group recognizes such changes in equity based on its percentage of ownership interests. The resulting capital surplus recognized will be reclassified to profit or loss at the time of disposing the associate or joint venture on a prorate basis.

When the associate or joint venture issues new stock, and the Group's interest in an associate or a joint venture is reduced or increased as the Group fails to acquire shares newly issued in the associate or joint venture proportionately to its original ownership interest, the increase or decrease in the interest in the associate or joint venture is recognized in Additional Paid in Capital and Investment accounted for using the equity method. When the interest in the associate or joint venture is reduced, the cumulative amounts previously recognized in other comprehensive income are reclassified to profit or loss or other appropriate items. The aforementioned capital surplus recognized is reclassified to profit or loss on a pro rata basis when the Group disposes of the associate or joint venture.

The financial statements of the associate or joint venture are prepared for the same reporting period as the Group. Where necessary, adjustments are made to bring the accounting policies in line with those of the Group.

The Group determines at each reporting date whether there is any objective evidence that the investment in the associate or an investment in a joint venture is impaired in accordance with IAS 28 Investments in Associates and Joint Ventures. If this is the case the Group calculates the amount of impairment as the difference between the recoverable amount of the associate or joint venture and its carrying value and recognizes the amount in the 'share of profit or loss of an associate' in the statement of comprehensive income in accordance with IAS 36 Impairment of Assets. In determining the value in use of the investment, the Group estimates:

• (a) Its share of the present value of the estimated future cash flows expected to be generated by the associate or joint venture, including the cash flows from the operations of the associate and the proceeds on the ultimate disposal of the investment; or
• (b) The present value of the estimated future cash flows expected to arise from dividends to be received from the investment and from its ultimate disposal.

Because goodwill that forms part of the carrying amount of an investment in an associate or an investment in a joint venture is not separately recognized, it is not tested for impairment separately by applying the requirements for impairment testing goodwill in IAS 36 Impairment of Assets.

Upon loss of significant influence over the associate or joint venture, the Group measures and recognizes any remaining investment at its fair value. Any difference between the carrying amount of the associate or joint venture upon loss of significant influence and the fair value of the retaining investment and proceeds from disposal is recognized in profit or loss. Furthermore, if an investment in an associate becomes an investment in a joint venture or an investment in a joint venture becomes an investment in an associate, the entity continues to apply the equity method and does not remeasure the retained interest.

(13)Property, plant and equipment

Property, plant and equipment are stated at cost, net of accumulated depreciation and accumulated impairment losses, if any. Such cost includes the cost of dismantling and removing the item and restoring the site on which it is located and borrowing costs for construction in progress if the recognition criteria are met. Each part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately. When significant parts of property, plant and equipment are required to be replaced in intervals, the Company recognized such parts as individual assets with specific useful lives and depreciation, respectively. The carrying amount of those parts that are replaced is derecognized in accordance with the derecognition provisions of IAS 16 "Property, plant and equipment". When a major inspection is performed, its cost is recognized in the carrying amount of the plant and equipment as a replacement if the recognition criteria are satisfied. All other repair and maintenance costs are recognized in profit or loss as incurred.

Depreciation is calculated on a straight-line basis over the estimated economic lives of the following assets:

Buildings	10 to 25 years
Machinery	2 to 10 years
Vehicle	2 to 6 years
Office equipment	2 to 6 years
Other equipment	1 to 25 years

An item of property, plant and equipment or any significant part initially recognized is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset is recognized in profit or loss.

The property, plant and equipment's residual values, useful lives and methods of depreciation are reviewed at each financial year. If the expected values differ from the estimates, the differences are recorded as a change in accounting estimate.

(14)Leases

The Group assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. To assess whether a contract conveys the right to control the use of an identified asset for a period of time, the Group assesses whether, throughout the period of use, has both of the following:

• (a) the right to obtain substantially all of the economic benefits from use of the identified asset; and
• (b) the right to direct the use of the identified asset.

For a contract that is, or contains, a lease, the Group accounts for each lease component within the contract as a lease separately from non-lease components of the contract. For a contract that contains a lease component and one or more additional lease or non-lease components, the Group allocates the consideration in the contract to each lease component on the basis of the relative stand-alone price of the lease component and the aggregate standalone price of the non-lease components. The relative stand-alone price of lease and nonlease components shall be determined on the basis of the price the lessor, or a similar supplier, would charge the Group for that component, or a similar component, separately. If an observable stand-alone price is not readily available, the Group estimates the stand-alone price, maximising the use of observable information.

Group as a lessee

Except for leases that meet and elect short-term leases or leases of low-value assets, the Group recognizes right-of-use asset and lease liability for all leases which the Group is the lessee of those lease contracts.

At the commencement date, the Group measures the lease liability at the present value of the lease payments that are not paid at that date. The lease payments discount using the interest rate implicit in the lease, if that rate can be readily determined. If that rate cannot be readily determined, the Group uses it's incremental borrowing rate. At the commencement date, the lease payments included in the measurement of the lease liability comprise the following payments for the right to use the underlying asset during the lease term that are not paid at the commencement date:

• (a) fixed payments (including in-substance fixed payments), less any lease incentives receivable;
• (b) variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;
• (c) amounts expected to be payable by the lessee under residual value guarantees;
• (d) the exercise price of a purchase option if the Group is reasonably certain to exercise that option; and
• (e) payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease.

After the commencement date, the Group measures the lease liability on an amortised cost basis, which is increasing the carrying amount to reflect interest on the lease liability by using an effective interest method; and reducing the carrying amount to reflect the lease payments made.

At the commencement date, the Group measures the right-of-use asset at cost. The cost of the right-of-use asset comprises:

• (a) the amount of the initial measurement of the lease liability;
• (b) any lease payments made at or before the commencement date, less any lease incentives received;
• (c) any initial direct costs incurred by the lessee; and
• (d) an estimate of costs to be incurred by the lessee in dismantling and removing the underlying asset, restoring the site on which it is located or restoring the underlying asset to the condition required by the terms and conditions of the lease.

For subsequent measurement of the right-of-use asset, the Group measures the right-of-use asset at cost less any accumulated depreciation and any accumulated impairment losses. That is, the Group measures the right-of-use applying a cost model.

If the lease transfers ownership of the underlying asset to the Group by the end of the lease term or if the cost of the right-of-use asset reflects that the Group will exercise a purchase option, the Group depreciates the right-of-use asset from the commencement date to the end of the useful life of the underlying asset. Otherwise, the Group depreciates the right-of-use asset from the commencement date to the earlier of the end of the useful life of the right-ofuse asset or the end of the lease term.

The Group applies IAS 36 "Impairment of Assets" to determine whether the right-of-use asset is impaired and to account for any impairment loss identified.

Except for leases that meet and elect short-term leases or leases of low-value assets, the Group presents right-of-use assets and lease liabilities in the balance sheet and separately presents lease-related interest expense and depreciation charge in the statements' comprehensive income.

For short-term leases or leases of low-value assets, the Group elects to recognize the lease payments associated with those leases as an expense on either a straight-line basis over the lease term or another systematic basis.

Group as a lessor

At inception of a contract, the Group classifies each of its leases as either an operating lease or a finance lease. A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership of an underlying asset. A lease is classified as an operating lease if it does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset. At the commencement date, the Group recognizes assets held under a finance lease in its balance sheet and present them as a receivable at an amount equal to the net investment in the lease.

For a contract that contains lease components and non-lease components, the Group allocates the consideration in the contract applying IFRS 15.

The Group recognizes lease payments from operating leases as rental income on either a straight-line basis or another systematic basis. Variable lease payments for operating leases that do not depend on an index or a rate are recognized as rental income when incurred.

(15)Intangible assets

Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is its fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses, if any. Internally generated intangible assets, not meeting the recognition criteria, are not capitalized and expenditure is reflected in profit or loss for the year in which the expenditure is incurred.

The useful lives of intangible assets are assessed as either finite or indefinite.

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each financial year. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period or method, as appropriate, and are treated as changes in accounting estimates.

Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating unit (CGU) level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis.

Gains or losses arising from derecognition of an intangible asset are recognized in profit or loss.

The Group's accounting policies for intangible assets are as follows:

	Cost of Computer Software
Useful economic life	1 to 5 years
Amortization method	Straight-line method during the contract term
Internally generated or acquired externally	Acquired externally

(16)Impairment of non-financial assets

The Group assesses at the end of each reporting period whether there is any indication that an asset in the scope of IAS 36 "Impairment of Assets" may be impaired. If any such indication exists, or when annual impairment testing for an asset is required, the Group would conduct impairment tests at individual or CGU level. Where the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired. An asset's recoverable amount is the higher of an asset's net fair value or its value in use.

For assets excluding goodwill, an assessment is made at each reporting date as to whether there is any indication that previously recognized impairment losses may no longer exist or may have decreased. If such indication exists, the Group estimates the recoverable amount of the asset or CGU. A previously recognized impairment loss is reversed only if there has been an increase in the estimated service potential of an asset which in turn increases the recoverable amount. However, the reversal is limited so that the carrying amount of the asset does not exceed the carrying amount that would have been determined, net of depreciation or amortization, had no impairment loss been recognized for the asset in prior years.

A cash generating unit, or groups of cash-generating units, to which goodwill has been allocated is tested for impairment annually at the same time, irrespective of whether there is any indication of impairment. If an impairment loss is to be recognized, it is first allocated to reduce the carrying amount of any goodwill allocated to the cash generating unit (group of units), then to the other assets of the unit (group of units) pro rata on the basis of the carrying amount of each asset in the unit (group of units). Impairment losses relating to goodwill cannot be reversed in future periods for any reason.

Impairment loss or reversals of continuing operations are recognized in profit or loss.

(17)Provisions

Provisions are recognized when the Group has a present obligation (legal or constructive) as a result of a past event and it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. Where the Group expects some or all of a provision to be reimbursed, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects the risks specific to the liability. Where discounting is used, the increase in the provision due to the passage of time is recognized as a finance cost.

The liability to pay a levy is recognized progressively if the obligating event accurs over a period of time.

(18)Revenue recognition

The Group's revenue arising from contracts with customers mainly includes sale of goods and rendering of services. The accounting policies for the Group's types of revenue are explained as follows:

Sale of goods

The Group mainly manufactures and sells of its products. Sales are recognized when control of the goods is transferred to the customer and the goods are delivered to the customers. The main product of the Group is substrate and revenue is recognized based on the consideration stated in the contract. The remaining sales transactions are usually accompanied by volume discounts (based on the accumulated total sales amount for a specified period). Therefore, revenue from these sales is recognized based on the price specified in the contract, net of the estimated volume discounts. Accumulated experience is used to estimate and provide for the discounts, using the expected value method. Revenue is only recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. During the period specified in the contract, refund liability is recognized for the products expected to be returned.

The credit period of the Group's sale of goods is from 30 to 90 days. For most of the contracts, when the Group transfers the goods to customers and has a right to an amount of consideration that is unconditional, these contracts are recognized as trade receivables. The period between the time when the Group transfers the goods to customers and when the customers pay for that goods is usually short and have no significant financing component to the contract. In the case that the Group has the right to transfer the goods to customers but does not have a right to an amount of consideration that is unconditional, these contacts should be presented as contract assets. Moreover, in accordance with IFRS 9, the Group measures the loss allowance for a contract asset at an amount equal to the lifetime expected credit losses.

(19)Borrowing costs

Borrowing costs directly attributable to the acquisition, construction or production of an asset that necessarily takes a substantial period of time to get ready for its intended use or sale are capitalized as part of the cost of the respective assets. All other borrowing costs are expensed in the period they occur. Borrowing costs consist of interest and other costs that an entity incurs in connection with the borrowing of funds.

(20)Government grants

Government grants are recognized where there is reasonable assurance that the grant will be received and all attached conditions will be complied with. Where the grant relates to an asset, it is recognized as deferred income and recorded gains in equal amounts over the expected useful life of the related asset. When the grant relates to an expense item, it is recognized as income over the period necessary to match the grant on a systematic basis to the costs that it is intended to compensate.

Where the Group receives non-monetary grants, the asset and the grant are recorded gross at nominal amounts in the statement of comprehensive income over the expected useful life and pattern of consumption of the benefit of the underlying asset by equal annual installments. Where loans or similar assistance are provided by governments or related institutions with an interest rate below the current applicable market rate, the effect of this favorable interest is regarded as additional government grant.

(21)Post-employment benefits

All regular employees of Kinsus and its domestic subsidiaries are entitled to pension plans that are managed by an independently administered pension fund committee. Fund assets are deposited under the committee's name in the specific bank account and hence, not associated with Kinsus and its domestic subsidiaries. Therefore, fund assets are not included in the Group's consolidated financial statements. Pension benefits for employees of the overseas subsidiaries and the branches are provided in accordance with the respective local regulations.

For the defined contribution plan, Kinsus and its domestic subsidiaries will make a monthly contribution of no less than 6% of the monthly wages of the employees subject to the plan. The Company recognizes expenses for the defined contribution plan in the period in which the contribution becomes due. Overseas subsidiaries and branches make contribution to the plan based on the requirements of local regulations and the contribution is expensed as incurred.

Post-employment benefit plan that is classified as a defined benefit plan uses the Projected Unit Credit Method to measure its obligations and costs based on actuarial assumptions. Remeasurements, comprising of the effect of the actuarial gains and losses, the effect of the asset ceiling (excluding net interest) and the return on plan assets, excluding net interest, are recognized as other comprehensive income with a corresponding debit or credit to retained earnings in the period in which they occur. Past service costs are recognized in profit or loss on the earlier of:

• (a) the date of the plan amendment or curtailment, and
• (b) the date that the Company recognizes restructuring-related costs

Net interest is calculated by applying the discount rate to the net defined benefit liability or asset, both as determined at the start of the annual reporting period, taking account of any changes in the net defined benefit liability (asset) during the period as a result of contribution and benefit payment.

(22)Share-based payment transactions

The cost of equity-settled transactions between the Group and its subsidiaries is recognized based on the fair value of the equity instruments granted. The fair value of the equity instruments is determined by using an appropriate pricing model.

The cost of equity-settled transactions is recognized, together with a corresponding increase in other capital reserves in equity, over the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Group's best estimate of the number of equity instruments that will ultimately vest. The income statement expense or credit for a period represents the movement in cumulative expense recognized as at the beginning and end of that period.

No expense is recognized for awards that do not ultimately vest, except for equity-settled transactions where vesting is conditional upon a market or non-vesting condition, which are treated as vesting irrespective of whether or not the market or non-vesting condition is satisfied, provided that all other performance and/or service conditions are satisfied.

Where the terms of an equity-settled transaction award are modified, the minimum expense recognized is the expense as if the terms had not been modified, if the original terms of the award are met. An additional expense is recognized for any modification that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee as measured at the date of modification.

Where an equity-settled award is cancelled, it is treated as if it vested on the date of cancellation, and any expense not yet recognized for the award is recognized immediately. This includes any award where non-vesting conditions within the control of either the entity or the employee are not met. However, if a new award is substituted for the cancelled award, and designated as a replacement award on the date that it is granted, the cancelled and new awards are treated as if they were a modification of the original award, as described in the previous paragraph.

The dilutive effect of outstanding options is reflected as additional share dilution in the computation of diluted earnings per share.

The cost of restricted stocks issued is recognized as salary expense based on the fair value of the equity instruments on the grant date, together with a corresponding increase in other capital reserves in equity, over the vesting period. The Group recognized unearned employee salary which is a transitional contra equity account; the balance in the account will be recognized as salary expense over the passage of vesting period.

(23)Income tax

Income tax expense (benefit) is the aggregate amount included in the determination of profit or loss for the period in respect of current tax and deferred tax.

Current income tax

Current income tax assets and liabilities for the current and prior periods are measured at the amount expected to be recovered from or paid to the taxation authorities, using the tax rates and tax laws that have been enacted or substantively enacted by the end of reporting period.

Current income tax relating to items recognized in other comprehensive income or directly in equity is recognized in other comprehensive income or equity and not in profit or loss.

The income tax for undistributed earnings of the Company and its subsidiaries is recognized as income tax expense in the subsequent year when the distribution proposal is approved at the Shareholders' meeting.

Deferred income tax

Deferred income tax is a temporary difference between the tax bases of assets and liabilities and their carrying amounts in balance sheet at the reporting date.

Deferred tax liabilities are recognized for all taxable temporary differences, except:

(a) Where the deferred tax liability arises from the initial recognition of goodwill or of an asset or liability in a transaction that is not a business combination; at the time of the transaction, affects neither the accounting profit nor taxable profit (loss) ; and the time of the transaction, there was no equivalent taxable and deductible temporary difference.

(b) In respect of taxable temporary differences associated with investments in subsidiaries, and associates and interests in joint ventures, where the timing of the reversal of the temporary differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.

Deferred tax assets are recognized for all deductible temporary differences, any unused tax losses and carry forward of unused tax credits to the extent that it is probable that taxable profit will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax losses can be utilized, except:

• (a) Where the deferred tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination; at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and the time of the transaction, does not give rise to equal taxable and deductible temporary differences.
• (b) In respect of deductible temporary differences associated with investments in subsidiaries, associates and interests in joint ventures, deferred tax assets are recognized only to the extent that it is probable that the temporary differences will be reversed in the foreseeable future and taxable profit will be available against which the temporary differences can be utilized.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates and tax laws that have been enacted or substantively enacted at the reporting date. The measurement of deferred tax assets and liabilities reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Deferred tax relating to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the underlying transaction either in other comprehensive income or directly in equity. Deferred tax assets are reassessed and recognized at each reporting date.

Deferred tax assets and liabilities are offset, if a legally enforceable right exists to set off current income tax assets against current income tax liabilities and the deferred taxes relate to the same taxable entity and the same taxation authority.

According to the temporary exception in the International Tax Reform – Pillar Two Model Rules (Amendments to IAS 12), information about deferred tax assets and liabilities related to Pillar Two income tax will neither be recognized nor be disclosed.

5. SIGNIFICANT ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS

The preparation of the Group's consolidated financial statements requires management to make judgments, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures, and the disclosure of contingent liabilities. However, uncertainty about these assumptions and estimates could result in outcomes that require a material adjustment to the carrying amount of assets or liabilities affected in future periods.

(1) Judgement

In the process of applying the Company's accounting policies, management has made the following judgements, which have the most significant effect on the amounts recognized in the consolidated financial statements:

A. De facto control without a majority of the voting rights in subsidiaries

The Company does not have majority of the voting rights in certain subsidiaries. However, after taking into consideration factors such as absolute size of the Company's holding, relative size of the other shareholdings, how widely spread are the remaining shareholders, contractual arrangements between shareholders, potential voting rights, etc., the Company reached the conclusion that it has de facto control over these subsidiaries. Please refer to Note 4 for further details.

(2) Estimates and assumptions

The key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date that would have a significant risk for a material adjustment to the carrying amounts of assets and liabilities within the next fiscal year are discussed below.

A. Fair value of financial instruments

Where the fair values of financial assets and financial liabilities recorded in the balance sheet cannot be derived from active markets, they are determined using valuation techniques including income approach (for example, the discounted cash flows model) or the market approach. Changes in assumptions about these factors could affect the reported fair value of the financial instruments. Please refer to Note 12 for more details.

B. Accounts receivables - estimation of impairment loss

The Group estimates the impairment loss of accounts receivables at an amount equal to lifetime expected credit losses. The credit loss is the present value of the difference between the contractual cash flows that are due under the contract (carrying amount) and the cash flows that expects to receive (evaluate forward looking information). However, as the impact from the discounting of short-term receivables is not material, the credit loss is measured by the undiscounted cash flows. Where the actual future cash flows are lower than expected, a material impairment loss may arise. Please refer to Note 6 for more details.

C. Inventory

Estimates of net realizable value of inventories take into consideration that inventories may be damaged, become wholly or partially obsolete, or their selling prices have declined. The estimates are based on the most reliable evidence available at the time the estimates are made. Please refer to Note 6 for more details.

D. Post-employment benefits

The cost of post-employment benefit pension plan and the present value of the defined benefit obligation are determined using actuarial valuations. An actuarial valuation involves making various assumptions, including the change in the discount rate and expected salary level.

E. Share-based payment transactions

The Group measures the cost of equity-settled transactions with employees by reference to the fair value of the equity instruments at the date at which they are granted. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining the most appropriate inputs to the valuation model including the expected life of the share option, volatility and dividend yield and making assumptions about them. The assumptions and models used for estimating fair value for share-based payment transactions are disclosed in Note 6.

F. Revenue recognition - sale returns and allowances

The Group estimates sales returns and allowance based on historical experience and other known factors at the time of sale, which reduces the operating revenue. In assessing the aforementioned sales returns and allowance, on the basis of highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Please refer to Note 6 for more details.

G. Income tax

Uncertainties exist with respect to the interpretation of complex tax regulations and the amount and timing of future taxable income. Given the wide range of international business relationships and the long-term nature and complexity of existing contractual agreements, differences arising between the actual results and the assumptions made, or future changes to such assumptions, could necessitate future adjustments to tax income and expense already recorded. The Group establishes provisions, based on reasonable estimates, for possible consequences of audits by the tax authorities of the respective counties in which it operates. The amount of such provisions is based on various factors, such as experience of previous tax audits and differing interpretations of tax regulations by the taxable entity and the responsible tax authority. Such differences of interpretation may arise on a wide variety of issues depending on the conditions prevailing in the respective Group company's domicile.

Deferred tax assets are recognized for all carryforward of unused tax losses and unused tax credits and deductible temporary differences to the extent that it is probable that taxable profit will be available or there are sufficient taxable temporary differences against which the unused tax losses, unused tax credits or deductible temporary differences can be utilized. The amount of deferred tax assets determined to be recognized is based upon the likely timing and the level of future taxable profits and taxable temporary differences together with future tax planning strategies.

6. CONTENTS OF SIGNIFICANT ACCOUNTS

(1)Cash and cash equivalents

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Cash and petty cash	\$5,106	\$4,882
Checks and savings	3,405,376	3,031,777
Time deposit(Note)	8,870,755	11,362,992
Total	\$12,281,237	\$14,399,651

Note: The contract will expire within three months and it must be readily convertible to a know amount of cash and be subject to an insignificant risk of change in value.

(2)Financial assets at fair value through profit or loss

	As of December 31,
	2025	2024
Mandatorily measured at fair value through profit or loss:	(NT\$'000)	(NT\$'000)
Money market fund	\$1,404,707	\$1,116,752
Valuation adjustment	5,587	4,626
Total	\$1,410,294	\$1,121,378
Current	\$1,410,294	\$1,121,378
Non-current	\$-	\$-

No financial asset at fair value through profit or loss was pledged as collateral.

(3)Financial assets measured at amortized cost

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Restricted Deposit	\$1,197	\$-
Time deposit	2,680,200	1,154,989
Total	\$2,681,397	\$1,154,989
Current	\$2,644,290	\$1,154,989
Non-current	\$37,107	\$-

The Group transacts with financial institutions with good credit rating. Consequently, there is no significant credit risk.

No financial asset measured at amortized cost was pledged as collateral.

(4)Financial assets at fair value through other comprehensive income

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Equity instruments investments measured at
fair value through other comprehensive
income – non-current:
Unlisted company stocks	\$118,830	\$51,000
Valuation adjustment	(66,103)	-
Total	\$52,727	\$51,000

No financial assets at fair value through other comprehensive income was pledged by the Group as collateral.

(5)Notes receivable

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Notes receivable arising from operating	\$-	\$2,730
activities
Less: loss allowance	-	-
Total	\$-	\$2,730

Notes receivable were not pledged.

The Group follows the requirement of IFRS 9 to assess the impairment. Please refer to Note 6(24) for more details on loss allowance and Note 12 for details on credit risk.

(6)Accounts receivable and accounts receivable - related parties, net

A.Accounts receivable, net

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Accounts receivable, gross	\$6,814,025	\$5,300,765
Less: loss allowances	(11,264)	(19,124)
Subtotal	6,802,761	5,281,641
Accounts receivable - related parties, gross	867	-
Less: loss allowances	-	-
Subtotal	867	-
Total accounts receivable, net	\$6,803,628	\$5,281,641

B.Accounts receivable were not pledged.

C.The term of accounts receivable are generally 30 to 90 days. The total carrying amount for the years ended December 31, 2025 and 2024 were NT\$6,814,892 thousand and NT\$5,300,765 thousand, respectively. Please refer to Note 6 (24) for more details on loss allowance of accounts receivable for the years ended December 31, 2025and 2024. Please refer to Note 12 for more details on credit risk management.

(7)Inventories

A. Details of inventory:

		As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Raw material	\$799,270	\$461,253
Supplies	59,558	56,560
Work in process	2,440,862	1,384,055
Finished goods	1,437,163	1,003,255
Merchandises	91,456	76,318
Total	\$4,828,309	\$2,981,441

• B. For the years ended December 31, 2025 and 2024, the Group recognized NT\$31,036,687 thousand and NT\$21,867,254 thousand as the cost of inventory, respectively, including loss from inventory market decline, physical or inventory write-off obsolescence. For the years ended December 31, 2025 and 2024, the expenses and losses amounted to NT\$3,955,245 thousand and NT\$2,875,441 thousand, respectively.
• C. The inventories were not pledged.

(8) Disposal groups held for sale

	As of December 31,
	2024
	(NT\$'000)
Assets of disposal groups held for sale	\$3,603,466
Liabilities directly associated with disposal groups held for sale	\$1,499,857

On December 31, 2024, the Board of Directors resolved to indirectly sell its entire 80.50% ownership in KINSUS HOLDING (CAYMAN) LTD and 100.00% ownership in PIOTEK HOLDINGS LIMITED. The details of related assets and liabilities held for sale were as follows:

	As of December 31,
	2024
	(NT\$'000)
Assets of disposal groups held for sale
Cash and cash equivalents	\$966,002
Other receivables	18,125
Inventories, net	347,771
Prepayments	31,327
Other current assets	89,769
Property, plant and equipment	1,982,174
Right-of-use assets	158,477
Intangible assets	5,032
Other non-current assets	4,789
Total	\$3,603,466
Liabilities directly associated with disposal groups held for sale
Short-term loans	\$891,011
Accounts payable	349,201
Other payables	216,867
Current tax liabilities	11,446
Other current liabilities	598
Other non-current liabilities	30,734
Total	\$1,499,857

As the sales proceeds of the disposal are expected to exceed the carrying amount of the related net assets, no impairment losses were recognized on the classification of these operations as disposal groups held for sale.

On December 30, 2024, the Group's subsidiaries, KINSUS HOLDING (SAMOA) LIMITED and PIOTEK HOLDINGS LTD. (CAYMAN), entered into a share purchase agreement with Cornucopia Investment Advisory and Management Partners Inc., which materially stipulates the following:

• A. KINSUS HOLDING (SAMOA) LIMITED sells 80.5% of the equity interest in KINSUS HOLDING (CAYMAN) LTD and indirectly transfers Suzhou Tongshuo Technology Co., Ltd. - invested by KINSUS HOLDING (CAYMAN) LTD with a total transaction amount of RMB 1,218,770 thousand.
• B. PIOTEK HOLDINGS LTD. (CAYMAN) sells 100% equity interest in PIOTEK HOLDINGS LIMITED and indirectly transfers Piotek Computer (Suzhou) Co., Ltd. invested by PIOTEK HOLDINGS LIMITED with a total transaction amount of RMB 309,111 thousand.

The equity transfer of this transaction is conducted in two phases, with the first phase involving the sale of 70% equity in KINSUS HOLDING (CAYMAN) LTD and 100% equity in PIOTEK HOLDINGS LIMITED; in the second phase, 10.5% equity in KINSUS HOLDING (CAYMAN) LTD will be sold.

Because a agreement for the plan was not reached, the case was cancelled by a resolution of the board of directors on April 28, 2025. The asset was reclassified from the Disposal groups held for sale.

(9) Investments accounted for under the equity method

As of December 31,
			2024
Carrying		Carrying	Percentage of
amount	ownership	amount	ownership
(NT\$'000)	(%)	(NT\$'000)	(%)
\$-	-%	\$-	-%
48,521	25.00%	49,377	25.00%
\$48,521		\$49,377
		2025 Percentage of

A. The Company invested cash in FuYang Technology Corp. during May 2016 for interest ownership of 36%. The investment is accounted for as an investment in associates due to the Company's ability to exercise its significant influence.

In May 2017, the Company participated in FuYang's cash offering by disproportionately investing NT\$479,422 thousand for 19,176,872 shares of FuYang and, therefore, recognized a capital surplus amounting to NT\$7,484 thousand. As a result of the offering, the Company's share interest on FuYang decreased to 35.65%.

FuYang Technology Corp. was dissolved and liquidated by the resolution of the board of directors on March 5, 2024, and received the distribution of the remaining property NT\$395,835 thousand in December of the same year, and the remaining NT\$1,412 thousand was distributed in July 2026. As of December 31, 2025, FuYang Technology Corp. completed its liquidation and dissolution.

In September 2023, the Group's subsidiaries, Kinsus Investment Co., Ltd. and PEGAVISION CORPORATION invested cash in Zhuhe Investment Co., Ltd. with amounts of NT\$30,000 thousand and NT\$20,000 thousand, with shareholding ratios of 17.65% and 11.76%, respectively. Each obtained one seat in the board of directors of Zhuhe Investment Co., Ltd. The investment is accounted for as an investment in associates due to the Group's ability to exercise its significant influence.

In June 12, 2024, Zhuhe Investment Co., Ltd. conducted a cash capital increase. The Group did not subscribe to the shares proportionately, thereby reducing its ownership from 29.41% to 25.00%. An additional capital surplus in the amount of NT\$42 thousand was recognized for the non-proportionate subscription.

B. Investments in associates

As of December 31, 2025 and 2024, the aggregate carrying amount of the Group's interests in FuYang Technology Corp. and Zhuhe Investment Co., Ltd. was NT\$48,521 thousand and NT\$49,377 thousand, respectively. The aggregate financial information based on Group's share of FuYang Technology Corp. and Zhuhe Investment Co., Ltd. was as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Net profit (loss) from continuing operations	\$(856)	\$5,055
Other comprehensive income (post-tax)	-	-
Total comprehensive income	\$(856)	\$5,055

There were no contingent liabilities or capital commitments with respect to the investment in the associate as of December 31, 2025 and 2024. Nor any of the Group's share interest on FuYang was pledged as collateral.

• C. The Group's investment accounted for using equity method in Zhuhe Investment as of December 31, 2025 and 2024 amounted to NT\$48,521 thousand and NT\$49,377 thousand while the related shares of investment income/loss and joint venture income accounted for using the equity method amounted to NT\$(856) thousand and NT\$5,055 thousand for the year ended December 31, 2025 and 2024. And other comprehensive income were both NT\$0 for the year ended December 31, 2025 and 2024. They were measured based on the audited financial statements of the investee for the same correspondent periods.
• D. No investment accounted for under equity method was pledged as collateral as of December 31, 2025 and 2024.

		As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Owner occupied property, plant and equipmen	\$41,936,711	\$36,408,840

(10)Property, plant and equipment

A.Property, plant and equipment

							Construction in
							progress
							and equipment
							awaiting
							inspection
							(including
							prepayment for
				Office		Other	property and
	Land	Buildings	Machinery	Equipment	Vehicle	Equipment	equipment)	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Cost:
As of 1/1/2025	\$8,228,180	\$11,797,118	\$38,912,419	\$428,135	\$19,588	\$9,594,203	\$16,582,266	\$85,561,909
Reclassification	-	2,746,614	3,652,726	60,714	12,939	1,169,299	147,467	7,789,759
Addition	-	6,711	64,926	533	-	513,403	5,648,985	6,234,558
Disposals	-	(262,967)	(8,567,163)	(41,930)	(10,125)	(2,607,581)	-	(11,489,766)
Effect of EX rate	(317)	(97,829)	(67,487)	(1,421)	(393)	(26,104)	(11,881)	(205,432)
Other changes	-	4,239,420	1,316,031	177,048	2,763	7,549,432	(13,284,694)	-
As of 12/31/2025	\$8,227,863	\$18,429,067	\$35,311,452	623,079	\$24,772	\$16,192,652	\$9,082,143	\$87,891,028
As of 1/1/2024	\$6,315,776	\$11,255,795	\$37,213,996	\$432,772	\$31,893	\$8,777,126	\$21,089,836	\$85,117,194
Reclassification	-	(2,746,614)	(3,652,726)	(60,714)	(12,939)	(1,169,299)	(147,467)	(7,789,759)
to groups held
for sale
Addition	(213)	83,420	841	120	-	494,820	8,976,106	9,555,094
Disposals	-	-	(1,296,270)	(3,303)	-	(415,720)	-	(1,715,293)
Effect of EX rate	(283)	161,671	147,385	2,953	634	55,281	27,032	394,673
Other changes	1,912,900	3,042,846	6,499,193	56,307	-	1,851,995	(13,363,241)	-
As of 12/31/2024	\$8,228,180	\$11,797,118	\$38,912,419	\$428,135	\$19,588	\$9,594,203	\$16,582,266	\$85,561,909

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

							Construction in
							progress
							and equipment
							awaiting
							inspection
							(including
							prepayment for
				Office		Other	property and
	Land	Buildings	Machinery	Equipment	Vehicle	Equipment	equipment)	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Depreciation and impairment:
As of 1/1/2025	\$-	\$3,582,052	\$26,269,437	\$311,129	\$13,873	\$6,346,762	\$-	\$36,523,253
Reclassification	-	1,851,947	2,909,864	55,341	12,261	978,172	-	5,807,585
Depreciation	-	812,538	4,412,057	79,138	2,970	1,801,039	-	7,107,742
Disposal	-	(262,967)	(8,430,162)	(41,930)	(10,125)	(2,605,627)	-	(11,350,811)
Effect of EX rate	-	(66,477)	(47,683)	(1,153)	(372)	(18,513)	-	(134,198)
As of 12/31/2025	\$-	\$5,917,093	\$25,113,513	\$402,525	\$18,607	\$6,501,833	\$-	\$37,953,571
As of 1/1/2024	\$-	\$4,656,197	\$26,078,350	\$300,121	\$22,596	\$6,624,895	\$-	\$37,682,159
Reclassification to	-	(1,851,947)	(2,909,864)	(55,341)	(12,261)	(978,172)	-	(5,807,585)
groups held for
sale
Depreciation	-	652,988	4,201,622	66,910	2,958	1,067,935	-	5,992,413
Impairment loss	-	19,242	-	-	-	-	-	19,242
Disposal	-	-	(1,235,007)	(3,303)	-	(415,498)	-	(1,653,808)
Effect of EX rate	-	105,572	134,336	2,742	580	47,602	-	290,832
As of 12/31/2024	\$-	\$3,582,052	\$26,269,437	\$311,129	\$13,873	\$6,346,762	\$-	\$36,523,253
Net carrying amount:
As of 12/31/2025	\$8,227,863	\$12,511,974	\$10,197,939	\$220,554	\$6,165	\$9,690,819	\$9,082,143	\$49,937,457
As of 12/31/2024	\$8,228,180	\$8,215,066	\$12,642,982	\$117,006	\$5,715	\$3,247,441	\$16,582,266	\$49,038,656

B."Significant components" of buildings primarily comprised the main buildings and the facilities, which are depreciated based on their respective useful lives of 20 to 25 years and 3 to 20 years.

C.Details of property, plant & equipment and prepayment for property and machinery are as follows:

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Property, plant and equipment	\$41,936,711	\$36,408,840
Prepayment for property and equipment	8,000,746	12,629,816
Total	\$49,937,457	\$49,038,656

• D.The Group recognized an impairment loss in the amount of NT\$19,242 thousand on certain real estate to an extent of the recoverable value of \$0 in 2024. This impairment loss or gain from recovery has been recorded in the Group's statements of comprehensive incomes. The recoverable amount is measured at the value in use by the identified individual asset.
• E. Please refer to Note 8 for details on property, plant and equipment pledged as collaterals.
• F. The Company purchased 40 parcels of land with a total area of 36,115.24 square meters. Lands are located at the addresses of No. 1113, 1114, 1438 to 1443,1479,1486 to 1487 at ShiLeiZi Sub-section, ShiLeiZi Section, No. 1044, 1047 to 1049 at QingHua Section, and No. 0001 at RongHua Section, and No. 697 to 700 and 712 to 726 at DaPu Section, XinFeng Village. Due to regulatory restrictions, the agricultural land cannot be registered under the Company's name while it has been temporarily registered under the CEO and general manager's name and, to secure the Company's right to the land, mortgage registration has been created with the Company being the obligee.

(11)Intangible assets

	Computer software
	(NT\$'000)
Cost:
As of 1/1/2025	\$150,040
Reclassification	9,088
Additions – acquired separately	201,669
Derecognized upon retirement	(73,681)
Effect of exchange rate changes	(182)
As of 12/31/2025	286,934
As of 1/1/2024	\$126,660
Reclassification to groups held for sale	(9,088)
Additions – acquired separately	83,926
Derecognized upon retirement	(51,730)
Effect of exchange rate changes	272
As of 12/31/2024	\$150,040
Amortization and Impairment:
As of 1/1/2025	\$96,723
Reclassification	4,056
Amortization	84,575
Derecognized upon retirement	(73,681)
Effect of exchange rate changes	(9)
As of 12/31/2025	\$111,664
As of 1/1/2024	\$84,816
Reclassification to groups held for sale	(4,056)
Amortization	67,535
Derecognized upon retirement	(51,730)
Effect of exchange rate changes	158
As of 12/31/2024	\$96,723

	Computer software
	(NT\$'000)
Carrying amount, net:
As of 12/31/2025	\$175,270
As of 12/31/2024	\$53,317

Amounts of amortization recognized for intangible assets are as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Cost of goods sold	\$13,889	\$126
General and administrative	68,751	66,240
Research and development	1,935	1,169
Total	\$84,575	\$67,535

(12)Other non-current assets

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Refundable deposits	\$61,283	\$54,272
Net defined benefit assets	61,796	48,156
Total	\$123,079	\$102,428

(13)Short-term loans

			As of December 31,
	Interest interval	2025	2024
	(%)	(NT\$'000)	(NT\$'000)
Unsecured bank loans	1.70%~4.38%	\$3,053,498	\$2,451,503

As of December 31, 2025 and 2024, the line of unused short-term loan credit for the Group amounted to NT\$17,962,014 thousand and NT\$16,284,508 thousand, respectively.

(14)Other payable

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Accrued expense	\$4,502,639	\$3,535,525
Equipment payable	1,606,470	1,470,438
Accrued interest	13,074	15,578
Payable for restricted stock	8,280	-
Total	\$6,130,463	\$5,021,541

(15)Other current liabilities

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Other current liabilities	\$118,468	\$142,589
Current portion of long-term loans	4,197,755	3,016,554
Deferred revenue	23,005	14,729
Total	\$4,339,228	\$3,173,872

(16)Refund liability

		As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Refund liability	\$392,880	\$294,908

(17)Long-term loans

Details of long-term loans were as follows:

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Unsecured bank loans	\$15,245,884	\$16,565,832
Secured bank loans	148,998	229,906
Subtotal	15,394,882	16,795,738
Less: current portion	(4,197,755)	(3,016,554)
Total	\$11,197,127	\$13,779,184
Interest interval (%)	1.275% ~5.175%	1.15% ~6.23%

(a)The above long-term loans will mature at various times between 2026 and 2036.

(b)Borrowing and repayment

In consideration of the fund use and the terms of the loan agreement, the Group repaid the long-term loans of NT\$3,186,156 thousand and NT\$1,887,641 thousand for the years ended December 31, 2025 and 2024, respectively. In addition, the Group proceeded with long-term loans of NT\$1,755,000 thousand and NT\$1,577,369 thousand for the years ended December 31, 2025 and 2024, respectively. Please refer to Note 6(27)(D) for interest expenses.

(c)Collateral for bank loans

Please refer to Note 8 for details on assets pledged as collaterals.

(d)Government low-interest loan

The Group obtained government low-interest loans. The loans were measured at its fair value by applying the market interest rate. The deferred differences between the amounts paid and the fair value were classified as other current liabilities and other non-current liabilities, respectively.

(18)Other non-current liabilities

(a) Details of other non-current liabilities were as follows:

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Deposits received	\$5,012,637	\$5,433,639
Deferred revenue	18,410	77,927
Total	\$5,031,047	\$5,511,566

(b) The details of the deferred government grants income for the years ended December 31, 2025 and 2024 are as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Beginning balance	\$92,656	\$115,425
Received during the period	1,864	3,799
Released to the statement of	(46,612)	(26,568)
comprehensive income
Other	(6,493)	-
Ending Balance	\$41,415	\$92,656
Current	\$23,005	\$14,729
Non-current	\$18,410	\$77,927

(c) Please refer to Note 6(17) for details on interest rate of deferred government grants income.

(19)Post-employment benefits

Defined contribution plan

The Company and its domestic subsidiaries adopt a defined contribution plan in accordance with the Labor Pension Act of the R.O.C. Under the Labor Pension Act, the Company and its domestic subsidiaries will make monthly contributions of no less than 6% of the employees' monthly wages to the employees' individual pension accounts. The Company and its domestic subsidiaries have made monthly contributions of 6% of each individual employee's salaries or wages to employees' pension accounts.

Subsidiaries located in the People's Republic of China will contribute social welfare benefits based on a certain percentage of employees' salaries or wages to the employees' individual pension accounts.

Pension benefits for employees of overseas subsidiaries and branches are provided in accordance with the local regulations.

Expenses under the defined contribution plan for the years ended December 31, 2025 and 2024 were NT\$214,563 thousand and NT\$200,958 thousand, respectively.

Pension expenses for the years ended December 31, 2025 and 2024 were NT\$126 thousand and NT\$0, respectively.

Defined benefits plan

Kinsus and its domestic subsidiaries adopt a defined benefit plan in accordance with the Labor Standards Act of the R.O.C. The pension benefits are disbursed based on the units of service years and the average salaries in the last month of the service year. Two units per year are awarded for the first 15 years of services while one unit per year is awarded after the completion of the 15th year. The total units shall not exceed 45 units. Under the Labor Standards Act, Kinsus and its domestic subsidiaries contribute an amount equivalent to 2% of the employees' total salaries and wages on a monthly basis to the pension fund deposited at the Bank of Taiwan in the name of the administered pension fund committee. Before the end of each year, the Company and its domestic subsidiaries assess the balance in the designated labor pension fund. If the amount is inadequate to pay pensions calculated for workers retiring in the same year, the Company and its domestic subsidiaries will make up the difference in one appropriation before the end of March the following year.

The Ministry of Labor is in charge of establishing and implementing the fund utilization plan in accordance with the Regulations for Revenues, Expenditures, Safeguard and Utilization of the Labor Retirement Fund. The pension fund is invested in-house or under mandate, based on a passive-aggressive investment strategy for long-term profitability. The Ministry of Labor establishes checks and risk management mechanism based on the assessment of risk factors including market risk, credit risk and liquidity risk, in order to maintain adequate manager flexibility to achieve targeted return without over-exposure of risk. With regard to utilization of the pension fund, the minimum earnings in the annual distributions on the final financial statement shall not be less than the earnings attainable from the amounts accrued from twoyear time deposits with the interest rates offered by local banks. Treasury Funds can be used to cover the deficits after the approval of the competent authority. As the Company does not participate in the operation and management of the pension fund, no disclosure on the fair value of the plan assets categorized in different classes could be made in accordance with paragraph 142 of IAS 19. The Group expects to contribute NT\$7,156 thousand to its defined benefit plan during the 12 months beginning after December 31, 2025.

As of December 31, 2025 and 2024, the maturities of Kinsus' defined benefit plan are both in 2037.

Pension costs recognized in profit or loss were as follows.

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Current period service costs	\$-	\$-
Net interest of defined benefit liability (asset)	(819)	(302)
Total	\$(819)	\$(302)

Reconciliation of liability (asset) of the defined benefit plan is as follows:

		As of
	12/31/2025	12/31/2024	01/01/2024
	(NT\$'000)	(NT\$'000)	(NT\$'000)
Defined benefit obligation	\$136,094	\$130,602	\$136,382
Plan assets at fair value	(197,890)	(178,758)	(159,439)
Other non-current liabilities – defined
benefit (asset) liability	\$(61,796)	\$(48,156)	\$(23,057)

Reconciliation of liability (asset) of the defined benefit liability is as follows:

	Present value of		Net defined
	defined benefit	Fair value of	benefit liability
	obligation	plan assets	(asset)
	(NT\$'000)	(NT\$'000)	(NT\$'000)
1/1/2024	\$136,382	\$(159,439)	\$(23,057)
Current service cost	-	-	-
Interest cost (revenue)	1,787	(2,089)	(302)
Past service cost and settlement	-	-	-
Subtotal	1,787	(2,089)	(302)
Remeasurement of defined benefit
liability/assets:
Actuarial gain/loss due to change in
population statistic assumptions	1,723	-	1,723
Actuarial gain/loss due to change in financial
assumptions	(7,236)	-	(7,236)
Experience gain/loss	1,303	(13,603)	(12,300)
Remeasurement of defined benefit assets	-	-	-
Subtotal	(4,210)	(13,603)	(17,813)
Benefits paid	(3,357)	3,357	-
Contributions by employer	-	(6,984)	(6,984)
Effect of exchange rate changes	-	-	-
12/31/2024	130,602	(178,758)	(48,156)
Current service cost	-	-	-

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

	Present value of defined benefit obligation (NT\$'000)	Fair value of plan assets (NT\$'000)	Net defined benefit liability (asset) (NT\$'000)
Interest cost (revenue)	2,220	(3,039)	(819)
Pasts service cost and settlement	-	-	-
Subtotal	2,220	(3,039)	(819)
Remeasurement of defined benefit liability/assets:
Actuarial gain/loss due to change in
population statistic assumptions	-	-	-
Actuarial gain/loss due to change in financial
assumptions	4,418	-	4,418
Experience gain/loss	1,967	(12,049)	(10,082)
Remeasurement of defined benefit assets	-	-	-
Subtotal	6,385	(12,049)	(5,664)
Benefits paid	(3,113)	3,113	-
Contributions by employer	-	(7,157)	(7,157)
Effect of exchange rate	-	-	-
12/31/2025	\$136,094	\$(197,890)	\$(61,796)

The actuarial assumptions used for the Company's defined benefit plan are shown below.

	As of December 31,
	2025	2024
Discount rate	1.45%	1.70%
Expected rate of salary increases	3.00%	3.00%

Sensitivity analysis

	For the year ended December 31,
	2025		2024
	(NT\$'000)		(NT\$'000)
	Increase	Decrease	Increase	Decrease
	in defined in defined benefit benefit obligation obligation		in defined	in defined
			benefit	benefit
			obligation	obligation
Discount rate increased by 0.5%	\$-	\$(8,658)	\$-	\$(8,717)
Discount rate decreased by 0.5%	9,404	-	9,496	-
Expected salary level increased by 0.5%	9,210	-	9,324	-
Expected salary level decreased by 0.5%	-	(8,573)	-	(8,652)

For the purpose of sensitivity analysis above, the Company calculated the impact on defined benefit obligation due to a reasonable and feasible change of one single assumption (i.e. discount rate or expected salary level) with other assumptions remaining equal. Please note that the sensitivity analysis has its limitation due to the co-relation between different actuarial assumptions and the rarity that only one assumption changes at a time.

The method used in the analysis is consistent for both current and prior years.

(20)Provisions

	Carbon fees
As of January 1, 2025	\$-
Arising during the period	24,312
As of December 31, 2025	\$24,312

A provision has been recognized for the carbon fee levied in accordance with the "Climate Change Response Act" and its related sub-laws. Based on relevant regulations and the estimated greenhouse gases emissions fromemissions sources that are required for inventory registration and verification for the current year, the Group is subject to carbon fees. However, due to uncertainties related to factors such as the application of inventory methodologies and technologies, the impact of operational activities on emissions, or the results of auditing operations by the competent authority, or the implementation results of the self-determined reduction plan, the Group has made its best estimate based on applicable regulations and currently available information. The carbon fee is expected to be paid by the end of May in the following year. In May 2025, the Company's self-determined reduction plan was approved by the central competent authority and has assessed that the annual designated targets will be met. These factors have been taken into consideration in the Company's estimation of the carbon fee.

(21)Equity

A. Common stock

As of December 31, 2025 and 2024, the Company's authorized capital were both NT\$6,000,000 thousand, each share at par value of NT\$10, divided into 600,000 thousand shares. As of December 31, 2025 and 2024, the Company's paid-in capital were NT\$4,567,920 thousand and NT\$4,566,494 thousand, respectively, divided into 456,792 thousand shares and 456,649 thousand shares, respectively. Each share represents a voting right and a right to receive dividends.

On February 15, 2022 and May 27, 2022, the Company's board of directors and shareholders' meetings resolved to increase the capital through an issuance of new 5,400 thousand shares of restricted stock for employees. The application has been approved by the FSC in the Order No. Financial-Supervisory-Securities-Corporate-1110347163 issued on June 23, 2022. The Company's board of directors resolved the measurement date was on August 19, 2022. The issue price per share is NT\$85.6, and issued 1,932 thousand shares.

On January 29, 2024, the Company passed the resolution in the board meeting to recover and cancel restricted stock awards, proceed with capital reduction of NT\$440 thousand, and to set January 30, 2024 as the reference date of capital reduction.

On July 29, 2024, the Company passed the resolution in the board meeting to recover and cancel restricted stock awards, proceed with capital reduction of NT\$490 thousand, and to set August 22, 2024 as the reference date of capital reduction.

On October 28, 2024, the Company passed the resolution in the board meeting to recover and cancel restricted stock awards, proceed with capital reduction of NT\$120 thousand, and to set October 29, 2024 as the reference date of capital reduction.

On February 17, 2025, the Company passed the resolution in the board meeting to recover and cancel restricted stock awards, proceed with capital reduction of NT\$97 thousand, and to set February 18, 2025 as the reference date of capital reduction.

On April 28, 2025, the Company passed the resolution in the board meeting to recover and cancel restricted stock awards, proceed with capital reduction of NT\$422 thousand, and to set April 29, 2025 as the reference date of capital reduction.

On July 28, 2025, the Company passed the resolution in the board meeting to recover and cancel restricted stock awards, proceed with capital reduction of NT\$363 thousand, and to set August 20, 2025 as the reference date of capital reduction.

On October 27, 2025, the company passed the resolution in the board meeting to recover and cancel restricted stock awards, proceed with capital reduction of NT\$222 thousand , and to set October 28, 2025 as the reference date of capital reduction.

As of December 31, 2025, the Company recovered restricted stock awards in the amount of NT\$207 thousand, which is not yet cancelled.

On January 29, 2024 and May 30, 2024, the Company's board of directors and shareholders' meetings resolved to increase the capital through an issuance of new 2,700 thousand shares of restricted stock for employees. The application has been approved by the FSC in the Order No. Financial-Supervisory-Securities-Corporate-1130348311 issued on July 3, 2024. The Company's board of directors resolved the measurement date was on August 23, 2024 and August 21,2025. The issue price per share is NT\$59.5 and NT\$50 , and issued 2,297 thousand shares and 264 thousand shares,respectively.

On October 27, 2025, the company's board of directors resolved to conduct a cash capital increase of up to NT\$700,000 thousand through the issuance of up to 70,000 thousand shares of common stock. The plan has been filed with and became effective upon approval by the financial supervisory commission . The expected issue price is NT\$145 per share , and the record date for the cash capital increase subscription is February 1, 2026. As of January 30, 2026, the aforementioned cash capital increase was still in the process of fund raising.

B. Capital surplus

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Additional paid-in capital	\$6,575,387	\$6,465,533
Differences between purchase price and carrying
amount arising from acquisition or disposal of
subsidiaries	52,567	52,567
Changes in ownership interests in subsidiaries	663,471	663,471
New shares of investee companies not purchased	42	42
in proportion to shareholding ratio
Shared-Based Payment	8,515	8,515
Restricted stock for employees	75,487	167,441
Other	8	8
Total	\$7,375,477	\$7,357,577

According to the Taiwan Company Act, the capital surplus shall not be used except for making good the deficit of the Company. When a company incurs no loss, it may distribute the capital surplus related to the income derived from the issuance of new shares at a premium or income from endowments received by the company up to a certain percentage of paid-in capital. The said capital surplus could be distributed in cash to its shareholders in proportion to the number of shares being held by each of them. Capital surplus related to long-term equity investments cannot be used for any purpose.

C. Appropriation of earnings and dividend policies

(a)Earning distribution

According to the Company's Articles of Incorporation, current year's earnings, if any, shall be distributed in the following order:

• a. Payment of all taxes and dues;
• b. Offset prior years' operation losses;
• c. Set aside 10% of the remaining amount as legal reserve. This restriction shall not apply when the statutory surplus reserve has reached the paid-in capital of the company.
• d. Set aside or reverse special reserve in accordance with law and regulations; and
• e. The distribution of the remaining portion, if any, will be recommended by the Board of Directors and resolved in the shareholders' meeting.

If the Company's dividends are distributed to shareholders or all or part of statutory surplus reserve and capital reserve in whole may be paid in cash, the Board of Directors have been authorized to approve by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, and report to the shareholders' meeting.

(b)Dividend policies

The Company is in an industry with versatile environment. For long-term financial planning requirements and to meet the shareholders' demand for cash, the Company's dividend policy aims for steadiness and balancing. Shareholder's dividend distributed each year cannot be less than 10% of distributed surplus earnings and cash dividends distributed each year cannot be less than 10% of the gross amount of dividends.

(c)Legal reserve

According to the Company Act, legal reserve shall be set aside until such amount equals total authorized capital. Legal reserve can be used to offset deficits. If the Company does not incur any loss, the portion of legal reserve exceeding 25% of the paid-in capital may be distributed to shareholders by issuing new shares or by cash in proportion to the number of shares held by each shareholder.

(d)Special reserve

When the Company distributes distributable earnings, it shall set aside to special reserve, an amount equal to "other net deductions from shareholders" equity for the current fiscal year, provided that if the Company has already set aside special reserve according to the requirements for the adoption of IFRS, it shall set aside supplemental special reserve based on the difference between the amount already set aside and other net deductions from shareholders' equity. For any subsequent reversal of other net deductions from shareholders' equity, the amount reversed may be distributed from the special reserve.

The FSC issued Order No. Financial-Supervisory-Securities-Corporate -1090150022 on March 31, 2021, which sets out the following provisions for compliance:

On a public company's first-time adoption of the IFRS, for any unrealized revaluation gains and cumulative translation adjustments (gains) recorded to shareholders' equity that the company elects to transfer to retained earnings by application of the exemption under IFRS 1, the company shall set aside special reserve. For any subsequent use, disposal or reclassification of related assets, the company can reverse the special reserve by proportion and transfer to retained earnings.

The Company did not incur any special reserve upon the first-time adoption of T-IFRS.

(e)The appropriations of earnings for the Year 2025 and 2024 were approved through the Board of Directors' meetings and shareholders' meetings held on January 30, 2026 and May 28, 2025, respectively. The details of the distributions are as follows:

			Dividend per share
	Appropriation of earnings		(in NT\$)
	2025
	(NT\$'000)	(NT\$'000)	2025	2024
Legal reserve	\$160,163	\$6,700
Appropriation (reversal)	(107,209)	(150,092)
of special reserve
Cash dividend	799,620	456,649	\$1.75	\$1.00
Total	\$1,066,992	\$313,257

Please refer to Note 6(26) for details on employees' compensation and remuneration to directors and supervisors.

Notes to Consolidated Financial Statements (Continued)

D. Non-controlling interests

	For the years	ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Beginning balance	\$8,225,938	\$7,464,237
Net income attributable to NCIs	1,121,392	1,282,161
Other comprehensive income attributable to
NCIs:
Exchange differences arising on translation	(57,560)	33,501
of foreign operations
Capital increase of subsidiaries in cash	-	2,984
Cash dividends from subsidiaries	(613,408)	(556,962)
Share-based payment transaction	-	-
Unrealised gains (losses) on financial assets	(34,930)	-
measured at fair value through other
comprehensive income
Changes in associates and joint ventures	-	17
accounted for using the equity method
Ending balance	\$8,641,432	\$8,225,938

(22)Share-based payment plans

Restricted stocks plan for employees

A.On May 27, 2022, the shareholders' meetings resolved to issue of 5,400 thousand shares of restricted stocks for employees. The grantee is limited to employees who meet certain conditions. The restricted stocks have been approved by the Securities and Futures Bureau. On July 25, 2022, the board of directors resolved to issue 2,063 thousand shares. The measurement date was on August 19, 2022 and total shares issued were 1,932 thousand. The unit market price as of the granted date was NT\$130.

On February 13, 2023, the board of directors resolved to issue of 2,036 thousand shares. The measurement date was on March 20, 2023 and total shares issued were 1,448 thousand. The unit market price as of the granted date was NT\$105.

On April 28, 2023, the board of directors resolved to issue of 456 thousand shares. The measurement date was on May 19, 2023 and total shares issued were 280 thousand. The unit market price as of the granted date was NT\$108.

The employees who acquire the above shares can subscribe shares at the price of NT\$85.6 per shares while the vesting conditions are as below.

i. Employee above level eight

Vesting conditions	Proportion of vested shares
Within 1 month starting the granted date	30% (Uncondition round up to thousand shares)
Within 8 months starting the granted date	20% (Uncondition round up to thousand shares)
Within 13 months starting the granted date	20% (Uncondition round down to thousand shares)
Within 20 months starting the granted date	10% (Uncondition round up to thousand shares)
Within 25 months starting the granted date	10% (Uncondition round up to thousand shares)
Within 32 months starting the granted date	Remaining shares

ii. Employee at level six through level seven

Vesting conditions	Proportion of vested shares
Within 1 month starting the granted date	30% (Uncondition round up to thousand shares)
Within 13 months starting the granted date	50% (Uncondition round down to thousand shares)
Within 25 months starting the granted date	Remaining shares

Restriction on employee's right after granted but before vested:

• (a)The granted employee commit to the custodian institution, and shall not sell, pledge, transfer, donate, or dispose in any other ways, the right of restricted stocks before achieving the vesting conditions.

• (b)After new shares of restricted stock are issued, the granted employee should immediately commit to the custodian institution, and may not to ask the trustee to return the restricted stock in any other reasons or ways before achieving the vesting conditions.

• (c)The restricted stock for employees can participate in receiving dividends during the vesting period.

• (d)The right to vote and elect in a shareholders' meeting shall be executed by custodian institution in accordance with related regulations.
• B.On May 30, 2024, the shareholders' meetings resolved to issue of 2,700 thousand shares of restricted stocks for employees. The grantee is limited to employees who meet certain conditions. The restricted stocks have been approved by the Securities and Futures Bureau. On July 29, 2024, the board of directors resolved to issue 2,355 thousand shares. The measurement date was on August 23, 2022 and total shares issued were 2,297 thousand. The unit market price as of the granted date was NT\$106.5.

On July 28, 2025 and December 22, 2025 , the board of directors resolved to issue of 274 thousand shares and 139 thousand shares . The measurement date was on August 21, 2025 and January 8, 2026 and total shares issued were 264 thousand and 134 thousand. The unit market price as of the granted date were NT\$100 and NT\$142.5 .

The employees who acquire the above shares can subscribe shares at the price of NT\$59.5、NT\$50 and NT\$72 per shares while the vesting conditions are as below.

i. Employee above level eight

Vesting conditions	Proportion of vested shares
Within 1 month starting the granted date	40%
Within 13 months starting the granted date	30%
Within 25 months starting the granted date	Remaining shares

ii. Employee at level six through level seven

Vesting conditions	Proportion of vested shares
Within 1 month starting the granted date	40%
Within 13 months starting the granted date	30%
Within 25 months starting the granted date	Remaining shares

Restriction on employee's right after granted but before vested:

• (a)The granted employee commit to the custodian institution, and shall not sell, pledge, transfer, donate, or dispose in any other ways, the right of restricted stocks before achieving the vesting conditions.
• (b)After new shares of restricted stock are issued, the granted employee should immediately commit to the custodian institution, and not to ask the trustee to return the restricted stock in any other reasons or ways before achieving the vesting conditions.
• (c)The restricted stock for employees can participate in receiving dividends during the vesting period.
• (d)During the vested period, if the Company conducts a capital reduction for cash return or other non-statutory capital reduction, the unvested RSAs shall be cancelled proportionally by the ration of such capital reduction. If the Company conducts a cash capital reduction for cash return, the returned cash shall be deposited in a trust/custody account and shall not be delivered to the employees until the vesting conditions are fulfilled; otherwise, the cash will be returned to the Company.
• (e)Mergers and Acquisitions: Unvested RSAs may be changed by the relevant agreements or plans for the mergers and acquisitions.
• (f)The right to vote and elect in a shareholders' meeting shall be executed by custodian institution in accordance with related regulations.
• (g)Other important terms and conditions: During the period when the granted RSAs are deposited in a trust/custody account, each executive must enter into an agreement authorizing the Company to, among others, negotiate, execute, modify, extend, rescind, and terminate the trust/custody agreement with the trustee/custodian, and give instructions to deliver, use, and dispose of any of the properties under the trust/custody, on their behalf, with full power and authority.
• C. On August 19, 2022, the issuance of 1,932 thousand restricted shares for employees resulted in the increase of capital reserve-employee stock option in the amount of NT\$146,059 thousand. The restricted stocks plan was invalidated as of December 31,

2025 and 49 thousand shares were recalled. As a result, the unearned employee compensation amounted to NT\$0.

On March 20, 2023, the issuance of 1,448 thousand restricted shares for employees resulted in the increase of capital reserve-employee stock option in the amount of NT\$130,637 thousand. The restricted stocks plan was invalidated as of December 31, 2025 and 68 thousand shares were recalled. As a result, the unearned employee compensation was NT\$0.

On May 19, 2023, the issuance of 280 thousand restricted shares for employees resulted in the increase of capital reserve-employee stock option in the amount of NT\$21,168 thousand. The restricted stocks plan was invalidated as of December 31, 2025 and 43 thousand shares were recalled. As a result, the unearned employee compensation was NT\$2 thousand.

On August 23, 2024, the issuance of 2,297 thousand restricted shares for employees resulted in the increase of capital reserve-employee stock option in the amount of NT\$113,702 thousand. The restricted stocks plan was invalidated as of December 31, 2025 and 92 thousand shares were recalled. As a result, the unearned employee compensation was NT\$9,851 thousand.

On August 21, 2025, the issuance of 264 thousand restricted shares for employees resulted in the increase of capital reserve - employee stock option amounting to NT\$10,560 thousand. The restricted stocks plan was invalidated as of December 31, 2025 and 0 shares were recalled. As a result, the unearned employee compensation was NT\$5,467 thousand.

On December 22, 2025 ,the Board of Directors resolved to increase capital through the issuance of 139 thousand shares of restricted employee stock , which also served as the subscription record date. The payment period was from December 31, 2025 to January 7, 2026 , and the capital increase effective date was January 8, 2026 , resulting in additional paid in capital-restriced employee stock of NT\$9,593 thousand. As a result, the unearned employee compensation was NT\$8,951 thousand.

D. The expense recognized for employee services received is shown in the following table.

	For the year December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Total expense arising from equity-settled
share-based payment transactions	\$41,124	\$72,498

(All share-based payments for equity delivery)

• E. The Company did not modify the share-based payment plan for the year ended December 31, 2025 and 2024.
• F. The Group's paid issuance of new shares with restricted employee rights shall be granted before October 10, 2024, in accordance with the "Questions and Answers on Whether the IFRS Q&A on the Handling of Restricted Employee Rights New Shares Issued by the Accounting Research and Development Foundation is Retroactively Applied" issued by the Securities and Futures Bureau of the Financial Supervisory Commission.
• (23)Sales

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Revenue from customer contracts
Sales of goods	\$39,144,489	\$30,227,136
Other operating revenue	206,607	307,843
Total	\$39,351,096	\$30,534,979

Analysis of revenue from contracts with customers during the year ended December 31, 2025 and 2024 are as follows:

A. Disaggregation of revenue

	For the year	ended December	31, 2025
	IC Substrate	Optics	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)
Sales of goods	\$32,105,238	\$7,039,251	\$39,144,489
Other	206,607	-	206,607
Total	\$32,311,845	\$7,039,251	\$39,351,096
Timing of revenue recognition:
At a point in time	\$32,311,845	\$7,039,251	\$39,351,096
	For the year	ended December	31, 2024
	IC Substrate	Optics	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)
Sales of goods	\$23,410,521	\$6,816,615	\$30,227,136
Other	307,843	-	307,843
Total	\$23,718,364	\$6,816,615	\$30,534,979
Timing of revenue recognition:
At a point in time	\$23,718,364	\$6,816,615	\$30,534,979
B. Contract balances
(a)Contract liabilities
		As of
	12/31/2025	12/31/2024	01/01/2024
	(NT\$'000)	(NT\$'000)	(NT\$'000)
Sales of goods	\$3,189,969	\$4,233,934	\$4,982,962
Customer loyalty programs	1,426	1,619	1,810
Total	\$3,191,395	\$4,235,553	\$4,984,772
Current	\$1,088,434	\$1,104,108	\$1,072,455
Non-Current	2,102,961	3,131,445	3,912,317
Total	\$3,191,395	\$4,235,553	\$4,984,772

The significant changes in the Group's balances of contract liabilities for the the years ended December 31, 2025 are as follows:

		Customer loyalty
	Sales of goods	programs
The opening balance transferred to revenue	\$(1,130,459)	\$(1,619)
Increase in receipts in advance during the
period (excluding the amount incurred and
transferred to revenue during the period)	86,494	1,426

The significant changes in the Group's balances of contract liabilities for the the years ended December 31, 2024 are as follows:

		Customer loyalty
	Sales of goods	programs
The opening balance transferred to revenue	\$(800,744)	\$(1,810)
Increase in receipts in advance during the
period (excluding the amount incurred and
transferred to revenue during the period)	51,716	1,619
(24)Expected credit losses
		For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Operating expenses – Expected credit losses (gains)
Account receivables	\$(7,856)	(\$49,561)

Please refer to Note 12 for more details on credit risk.

The Group measured the impairment against the other receivables reclassified from accounts receivable due to factoring agreements mainly based on the expected credit loss for 12 months of the counterparty financial institutions. As of December 31, 2025 and 2024, there were no other receivables past due. Furthermore, the Group assessed the related expected credit loss to be insignificant because the counterparty financial institutions are of good credit condition.

The Group measures the loss allowance of its accounts receivable (including notes receivable and accounts receivable) at an amount equal to lifetime expected credit losses. The assessment of the Group's loss allowance as of December 31, 2025 and 2024 are as follows:

A. The Group considers the grouping of accounts receivable by counterparties' credit rating, by geographical region and by industry sector and its loss allowance is measured by using a provision matrix. Details are as follows.

Group 1	Not past due				Past due
	(Note) (NT\$'000)	<=30 days (NT\$'000)	31-60 days (NT\$'000)	61-90 days (NT\$'000)	91-120 days (NT\$'000)	>=121 days (NT\$'000)	>=365 days (NT\$'000)	Total (NT\$'000)
Gross carrying amount	\$5,791,778	\$72,875	\$5,549	\$-	\$-	\$-	\$-	\$5,870,202
Loss ratio	-%	5%	15%	30%	50%	75%	100%
Lifetime expected credit losses	-	(3,644)	(832)	-	-	-	-	(4,476)
Subtotal	\$5,791,778	\$69,231	\$4,717	\$-	\$-	\$-	\$-	\$5,865,726
Group 2	Not past due			Past due
	(Note) (NT\$'000)	<=30 days (NT\$'000)	31-60 days (NT\$'000)	61-90 days (NT\$'000)	91-120 days (NT\$'000)	>=121 days (NT\$'000)	Individual evaluate	Total (NT\$'000)
Gross carrying amount	\$941,396	\$3,294	\$-	\$-	\$-	\$-	\$-	\$944,690
Loss ratio	0.72%	1%	-%	-%	-%	100%	100%
Lifetime expected credit losses	(6,755)	(33)	-	-	-	-	-	(6,788)
Subtotal	934,641	3,261	-	-	-	-	-	937,902
Carrying amount of
accounts receivable	\$6,726,419	\$72,492	\$4,717	\$-	\$-	\$-	\$-	\$6,803,628

As of December 31, 2025

As of December 31, 2024

Group 1	Not past due				Past due
	(Note)	<=30 days	31-60 days	61-90 days	91-120 days	>=121 days	>=365 days	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Gross carrying amount	\$4,329,435	\$116,805	\$44,451	\$-	\$-	\$-	\$-	\$4,490,691
Loss ratio	-%	5%	15%	30%	50%	75%	100%
Lifetime expected	-	(5,840)	(6,668)	-	-	-	-	(12,508)
credit losses Subtotal	\$4,329,435	\$110,965	\$37,783	\$-	\$-	\$-	\$-	\$4,478,183
Group 2	Not past due			Past due
	(Note)	<=30 days	31-60 days	61-90 days	91-120 days	>=121 days	Individual	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	evaluate	(NT\$'000)
Gross carrying amount	\$796,155	\$16,649	\$-	\$-	\$-	\$-	\$-	\$812,804
Loss ratio	0.81%	1%	5%	-%	-%	100%	100%
Lifetime expected	(6,450)	(166)	-	-	-	-	-	(6,616)
credit losses Subtotal	789,705	16,483	-	-	-	-	-	806,188
Carrying amount of
accounts

Note: all the Group's note receivables were not past due.

B. The movement in the provision for impairment of notes receivable and accounts receivable during the years ended December 31, 2025 and 2024 are as follows:

Notes receivable	Accounts receivable
(NT\$'000)	(NT\$'000)
\$-	\$19,124
-	(7,856)
-	(4)
\$-	\$11,264

English Translation of Consolidated Financial Statements and Footnotes Originally Issued in Chinese Kinsus Interconnect Technology Corp. Notes to Consolidated Financial Statements (Continued)

	Notes receivable (NT\$'000)	Accounts receivable (NT\$'000)
Beginning balance as of January 1, 2024	\$-	\$68,670
Addition/(reversal) for the current period	-	(49,561)
Effect of exchange rate	-	15
Ending balance as of December 31, 2024	\$-	\$19,124

(25)Leases

A. Group as a lessee

The Group leases various properties, including real estate such as land and buildings, mechanical equipment and transportation equipment. These leases have terms of between 1 and 50 years. Certain leases provide that without obtaining consent from the lessor, the Group may not, under its own discretion, lend, sublease, sell, use by others in other disguised form, or transfer the lease to another person

The effect of leases on the Group's consolidated financial position, financial performance and cash flows are as follows:

(a) Amounts recognized in the balance sheet

I. Right-of-use assets

	Transportation
Land	Buildings	equipment	Total
(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
\$274,647	\$182,035	\$-	\$456,682
240,374	-	-	240,374
63,844	58,216	1,533	123,593
-	(49,314)	-	(49,314)
(27,377)	(1,459)	-	(28,836)
\$551,488	\$189,478	\$1,533	\$742,499

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

			Transportation
	Land	Buildings	equipment	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
As of 1/1/2024	\$226,946	\$512,585	\$-	\$739,531
Reclassification to groups			-	(240,374)
held for sale	(240,374)	-
Addition	274,647	41,054	-	315,701
Disposals	-	(374,283)	-	(374,283)
Effect of exchange rate	13,428	2,679	-	16,107
As of 12/31/2024	\$274,647	\$182,035	\$-	\$456,682
Depreciation and impairment: As of 1/1/2025	\$4,391	\$81,417	\$-	\$85,808
Reclassification	81,897	-	-	81,897
Depreciation	10,277	40,928	242	51,447
Disposal	-	(42,297)	-	(42,297)
Effect of exchange rate	(2,857)	(326)	12	(3,171)
As of 12/31/2025	\$93,708	\$79,722	\$254	\$173,684
As of 1/1/2024	\$72,663	\$245,965	\$-	\$318,628
Reclassification to groups			-
held for sale	(81,897)	-		(81,897)
Depreciation	9,193	63,739	-	72,932
Disposals	-	(229,469)	-	(229,469)
Effect of exchange rate	4,432	1,182	-	5,614
As of 12/31/2024	\$4,391	\$81,417	\$-	\$85,808
Net carrying amount:
As of 12/31/2025	\$457,780	\$109,756	\$1,279	\$568,815
As of 12/31/2024	\$270,256	\$100,618	\$-	\$370,874

II.Lease liability

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Lease liabilities	\$115,949	\$105,119
Current	\$38,155	\$31,533
Non-current	77,794	73,586
Total	\$115,949	\$105,119

Please refer to Note 6(27) (D) for the interest on lease liability recognized for the years ended December 31, 2025 and 2024 and refer to Note 12(5) for the maturity analysis for lease liabilities as of December 31, 2025 and 2024.

(b) Income and costs relating to leasing activities

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
The expense relating to short-term leases	\$(59,803)	\$(44,386)
(rent expense)
The expense relating to leases of low-value	(652)	(3,130)
assets (Not including the expense relating
to short-term leases of law-value assets)
Income from subleasing right-of-use assets	245	241

As of December 31, 2025 and 2024, the portfolio of short-term leases of the Group to which it is committed at the end of the reporting period was dissimilar to the portfolio of short-term leases to which the short-term lease expense disclosed above and the amount of its lease commitments was NT\$0.

(c) Cash outflow relating to leasing activities

For the years ended December 31, 2025 and 2024, the Group's total cash outflow for leases amounted to NT\$102,368 thousand and NT\$113,814 thousand, respectively.

B. Group as a lessor

The Group has entered leases on plants. These leases have terms of between one and three years. These leases are classified as operating leases as they do not transfer substantially all the risks and rewards incidental to ownership of underlying assets.

	For the years ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Lease income for operating leases
Income relating to fixed lease payments	\$53,120	\$33,056

For operating leases entered into by the Group, the undiscounted lease payments to be received and a total of the amounts for the remaining years as of December 31, 2025 and 2024 are as follows:

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Less than one year	\$392	\$392
More than one year but less than five years	360	752
Total	\$752	\$1,144

(26)Summary statement of employee benefits, depreciation and amortization was as follows:

	For the year ended December 31,
	2025	2024
Related parties	(NT\$'000)	(NT\$'000)
Employee benefit
Salaries & wages	\$7,534,797	\$6,468,995
Labor and health insurance	592,099	529,246
Pension	214,689	200,958
Other employee benefit	427,412	391,459
Depreciation	7,159,189	6,065,345
Amortization	84,575	67,535

According to the resolution, not lower than 10% of profit of the current year is distributable as employees' compensation and no higher than 1% of profit of the current year is distributable as remuneration to directors and supervisors. However, the Company's accumulated losses shall have been covered.

The Company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, have the profit distributable as employees' compensation in the form of shares or in cash; and in addition, a report of such distribution is submitted to the shareholders' meeting. According to the amended Articles of Incorporation approved through the shareholder's meeting held on May 28, 2025, no lower than 25% of employee remuneration shall be allocated to grassroots employees. Information on the Board of Directors' resolution regarding the employees' compensation and remuneration to directors and supervisors can be obtained from the "Market Observation Post System" on the website of the TWSE.

Based on profitability and following the rule of not lower than 10% and not higher than 1%, the Company estimated the employees' compensation and the remuneration to directors and supervisors respectively, for the year ended December 31, 2025 and recorded them as employee benefits. As such, employees' compensation and remuneration to directors and supervisors for the year ended December 31, 2025 amounted to NT\$219,306 thousand and NT\$12,793 thousand, respectively, and for the year ended December 31, 2024 amounted to NT\$6,251 thousand and NT\$0, respectively. The employees' compensation and remuneration to directors and supervisors were recognized as salaries. The Company's Board has determined the employees' compensation and directors' remuneration, all in cash, to be NT\$219,306 thousand and NT\$12,793 thousand, respectively, in a meeting held on January 30 , 2026.

The actual distribution of the employee compensation and remuneration to directors and supervisors for the year ended December 31, 2024 were NT\$6,251 thousand and NT\$0, respectively. No material differences existed between the estimated amount for the year ended December 31, 2024 and the actual distribution of the employee compensation and remuneration to directors and supervisors.

(27)Non-operating incomes and expenses

A. Interest income

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Interest income
Financial assets measured at
amortized cost	\$385,608	\$530,300

B. Other income

	For the year ended December 31,
	2025 (NT\$'000)	2024 (NT\$'000)
Rent income	\$53,120	\$33,056
Government grants	46,612	26,568
Penalty income	108,182	-
Other income-others	189,621	137,931
Total	\$397,535	\$197,555

C. Other gains and losses

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Gain (loss) on disposal of property,	\$(28,734)	\$57,717
plant and equipment
Foreign exchange gain (loss), net	38,464	83,022
Gain on lease modification	568	1,805
Net gain of financial assets at fair	17,586	37,203
value through profit or loss
Dispose of investment interests using	-	10,533
the equity method
Gain on disposals of investments	415	-

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Impairment losses	-	(19,242)
Other losses	(1,776)	(1,838)
Total	\$26,523	\$169,200

D. Finance costs

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Interest on bank loans	\$389,656	\$392,365
Interests on lease liabilities	1,762	1,976
Total	\$391,418	\$394,341

(28)Components of other comprehensive income (OCI)

For the year ended December 31, 2025

		Reclassification		Income tax
	Arising during	during the		benefit	OCI,
	the period	period	Subtotal	(expense)	Net of tax
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Not to be reclassified to profit or
loss:
Remeasurement of defined benefits
plan	\$5,664	\$-	\$5,664	\$-	\$5,664
Unrealized valuation gains (losses)
from equity instrument
investments measured at fair
value through other
comprehensive income	(66,103)	-	(66,103)		(66,103)
May be reclassified to profit or
loss in subsequent period:

English Translation of Consolidated Financial Statements and Footnotes Originally Issued in Chinese Kinsus Interconnect Technology Corp. Notes to Consolidated Financial Statements (Continued)

Exchange differences arising on translation of foreign operations	(133,683)	-	(133,683)	87	(133,596)
Total OCI	\$(194,122)	\$-	\$(194,122)	\$(87)	\$(194,035)

For the year ended December 31, 2024

		Reclassification		Income tax
	Arising during	during the		benefit	OCI,
	the period	period	Subtotal	(expense)	Net of tax
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Not to be reclassified to profit or
loss:
Remeasurement of defined benefits
plan	\$17,813	\$-	\$17,813	\$-	\$17,813
May be reclassified to profit or
loss in subsequent period:
Exchange differences arising on	183,645	-	183,645	(52)	183,593
translation of foreign operations
Total OCI	\$201,458	\$-	\$201,458	\$(52)	\$201,406

(29)Income tax

A. The major components of income tax expense (income) are as follows:

Income tax expense (benefit) recognized in profit or loss

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Current income tax expense (income):
Current income tax payable	\$371,437	\$364,252
Adjustments in respect of current income tax of prior	(15,640)	(52,618)
periods
Deferred tax expense (income):
Deferred tax expense (income) relating to origination	14,080	(39,496)
and reversal of temporary differences
Total income tax expense	\$369,877	\$272,138

B. A reconciliation between tax expense and the product of accounting profit multiplied by applicable tax rates is as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Accounting profit before tax from continuing operations	\$3,087,205	\$1,603,188
Tax payable at the enacted tax rates	\$902,368	\$610,305
Surtax on Undistributed earnings	7,365	6,871
Tax effect of income tax-exempted	(243,862)	(274,237)
Tax effect of expenses not deductible for tax purposes	(16,016)	(15,056)
Tax effect of deferred tax assets/liabilities	(224,123)	192,815
Adjustments in respect of current income tax of prior	(15,640)	(52,618)
periods
Tax effect arising from the amendment to tax act	(40,215)	(195,942)
Total income tax expense recognized in profit or loss	\$369,877	\$272,138

C. Deferred tax assets (liabilities) relate to the following:

For the year ended December 31, 2025

			Deferred tax
		Deferred tax	income (expense)		Ending balance
	Beginning balance	income (expense)	recognized in	Exchange	as of Dec. 31,
	as of Jan. 1, 2025	recognized in P/L	OCI	adjustment	2025
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Temporary differences
Prepaid appreciation tax on
agricultural land	\$9,593	\$-	\$-	\$-	\$9,593
Loss for market price decline
and obsolete and slow	25,683	6,913	-	-	32,596
moving inventories
Gain on exchange	(77)	(9,032)	- -	-	(9,109)
Loss on exchange	2,909	(2,898)	-	-	11
Other	54,627	(4,070)	-	(90)	50,467

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

			Deferred tax
		Deferred tax	income (expense)		Ending balance
	Beginning balance	income (expense)	recognized in	Exchange	as of Dec. 31,
	as of Jan. 1, 2025	recognized in P/L	OCI	adjustment	2025
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Investments accounted for using the equity method	106	(106)	-	-	-
Investments accounted for using the equity method	(70,829)	(4,887)	87	-	(75,629)
Deferred tax income/(expense)		\$(14,080)	\$87	\$(90)
Net deferred tax assets/(liabilities)	\$22,012				\$7,929
Reflected in balance sheet as follows:
Deferred tax assets	\$92,918				\$92,667
Deferred tax liabilities	\$(70,906)				\$(84,738)

For the year ended December 31, 2024

			Deferred tax
		Deferred tax	income (expense)		Ending balance
	Beginning balance	income (expense)	recognized in	Exchange	as of Dec. 31,
	as of Jan. 1, 2024	recognized in P/L	OCI	adjustment	2024
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Temporary differences
Prepaid appreciation tax on
agricultural land	\$9,593	\$-	\$-	\$-	\$9,593
Loss for market price decline
and obsolete and slow	29,275	(3,592)	-	-	25,683
moving inventories
Gain on exchange	(3,266)	3,189	-	-	(77)
Loss on exchange	40	2,869	-	-	2,909
Other	8,957	45,717	-	(47)	54,627
Investments accounted for using	118	(12)		-	106
the equity method			-

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

	Beginning balance as of Jan. 1, 2024	Deferred tax income (expense) recognized in P/L	Deferred tax income (expense) recognized in OCI	Exchange adjustment	Ending balance as of Dec. 31, 2024
Investments accounted for using the equity method	(NT\$'000) (62,102)	(NT\$'000) (8,675)	(NT\$'000) (52)	(NT\$'000) -	(NT\$'000) (70,829)
Deferred tax income/(expense) Net deferred tax assets/(liabilities)	\$(17,385)	\$39,496	\$(52)	\$(47)	\$22,012
Reflected in balance sheet as follows:
Deferred tax assets	\$47,983				\$92,918
Deferred tax liabilities	\$(65,368)				\$(70,906)

D. Unrecognized deferred tax assets

As of December 31, 2025 and 2024, deferred tax assets that have not been recognized as they may not be used to offset future taxable income amounted to NT\$1,831,408 thousand and NT\$1,179,445 thousand, respectively.

E. Unused balance of deductible net operating loss within the Company was listed as follows:

		Unused balance
	Accumulated net		As of December 31,
Occurrence	operating loss	2025	2024	Expiration
year	(NT\$'000)	(NT\$'000)	(NT\$'000)	Year
2021	\$383	\$383	\$383	2031
2022	4,062	4,062	4,062	2032
2023	700,168	639	700,168	2033
2024	1,734,827	1,408,817	1,838,051	2034
2025	327	327	-	2035
		\$1,414,228	\$2,542,664

F. The assessment of income tax return

As of December 31, 2025, the assessment status of income tax returns of the Company and subsidiaries was as follows:

	The assessment of income tax returns
The Company	Assessed and approved up to 2022
Subsidiary - Pegavision Corporation	Assessed and approved up to 2023
Subsidiary - Kinsus Investment Co., Ltd.	Assessed and approved up to 2023
Subsidiary - BeautyTech Platform	Assessed and approved up to 2023
Corporation
Subsidiary - Mayin Investment Co., Ltd.	Assessed and approved up to 2023
Subsidiary - FacialBeau International	Assessed and approved up to 2023
Corporation
Subsidiary - FORIMART Corporation	It was established in 2024, so there is not yet
	been approved.

(30)Earnings per share

Basic earnings per share is calculated by dividing net profit for the year attributable to the common shareholders of the parent entity by the weighted average number of common shares outstanding during the year.

Diluted earnings per share amounts are calculated by dividing the net profit attributable to ordinary equity holders of the parent entity (after adjusting any influences)by the weighted average number of ordinary shares outstanding during the year plus the weighted average number of ordinary shares that would be issued on conversion of all the dilutive potential ordinary shares into ordinary shares.

A. Basic earnings per share

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Net income attributable to ordinary equity holders of the parent
company (in NT\$'000)	\$1,595,936	\$48,889
Weighted average number of ordinary shares outstanding for
basic earnings per share (in thousand shares)	455,289	453,754
Basic earnings per share (in NT\$)	\$3.51	\$0.11

B. Diluted earnings per share

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Net income attributable to ordinary equity holders of the
parent company (in NT\$'000)	\$1,595,936	\$48,889
Net income attributable to ordinary equity holders of the
parent company after dilution (NT\$'000)	\$1,595,936	\$48,889
Weighted average number of ordinary shares outstanding for
basic earnings per share (in thousand shares)	455,289	453,754
Effect of dilution:
Employee compensation-stock (in thousand shares)	1,388	67
Restricted stock for employees	391	26
Weighted average number of ordinary shares outstanding
after dilution (in thousand shares)	457,068	453,847
Diluted earnings per share (in NT\$)	\$3.49	\$0.11

No other transactions that would significantly change the outstanding common shares or potential common shares incurred during the period after reporting date and up to the approval date of financial statements.

(31)Subsidiary that has material non-controlling interests

Proportion of equity interest held by non-controlling interests:

		As of December 31,
Name	Country	2025	2024
PIOTEK HOLDINGS LTD. and its	China	49.00%	49.00%
subsidiary
Pegavision Corporation and its subsidiary	Taiwan	70.45%	70.45%

Accumulated balances of material non-controlling interest:

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
PIOTEK HOLDINGS LTD. and its subsidiaries	\$343,286	\$408,487
Pegavision Corporation and its subsidiary	\$8,298,146	\$7,817,451

Profit (loss) allocated to material non-controlling interest:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
PIOTEK HOLDINGS LTD. and its subsidiaries	\$(47,886)	\$(30,246)
Pegavision Corporation and its subsidiary	\$1,169,278	\$1,312,407

The summarized financial information of this subsidiary is provided below. This information is based on amounts before inter-company eliminations.

Summarized PIOTEK HOLDINGS LTD. and its subsidiaries information of profit or loss is as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Operating revenue	\$-	\$-
Loss from continuing operation	(97,734)	(61,726)
Total comprehensive income for the period	(133,075)	(7,809)

Summarized Pegavision Corporation and its subsidiaries information of profit or loss is as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Operating revenue	\$7,039,409	\$6,817,305
Profit from continuing operation	1,650,465	1,853,484
Total comprehensive income for the period	1,544,167	1,862,948

Summarized PIOTEK HOLDINGS LTD. and its subsidiaries information of financial position is as follows:

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Current assets	\$239,171	\$264,026
Non-current assets	466,877	575,136
Current liabilities	5,436	5,475
Non-current liabilities	-	-

Summarized Pegavision Corporation and its subsidiaries information of financial position is as follows:

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Current assets	\$6,536,007	\$5,917,524
Non-current assets	9,638,320	8,628,239
Current liabilities	3,817,766	2,790,150
Non-current liabilities	620,699	696,918

Summarized PIOTEK HOLDINGS LTD. and its subsidiaries cash flows information is as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Operating activities	\$(19,293)	\$(24,392)
Investing activities	64	(144)
Financing activities	-	(47,685)
Net increase in cash and cash equivalents	(30,220)	(58,007)

Summarized Pegavision Corporation and its subsidiaries cash flows information is as follows:

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Operating activities	\$2,658,464	\$4,200,815
Investing activities	(2,136,064)	(2,476,100)
Financing activities	(790,457)	(1,228,617)
Net increase/(decrease) in cash and cash equivalents	(293,499)	501,674

7. RELATED PARTY TRANSACTIONS

(1)Deal with related parties as of the end of the reporting period

Related parties and Relationship

Related parties	Relationship
Pegatron Corporation	Parent company
AzureWave Technologies (Shanghai) Inc.	Other related parties
COTEK ELECTRONICS(SUZHOU) CO., LTD.	Other related parties
Maintek Computer (Suzhou) Co., Ltd	Other related parties
Casetek Computer (Suzhou) Co., Ltd.	Other related parties
PEGATRON JAPAN INC	Other related parties
PEGATRON CZECH S.R.O	Other related parties
PEGA INTERNATIONAL LIMITED	Other related parties
Zhuhe Investment Co., Ltd.	Associate

(2)Significant transactions with related parties

A. Sales

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Parent company	\$18	\$40
Other related parties	852	-
Total	\$870	\$40

Selling prices and collection terms with related parties are similar to those to third party customers for the years ended December 31, 2025 and 2024. The collection terms are 30 to 90 days from the end of delivery month by telegraphic transfer.

B. Purchase

		For the year ended December 31,
	2025 2024
Related parties	(NT\$'000)	(NT\$'000)
Parent company	\$940	\$-

The Group purchases goods from related parties at price negotiated by both parties with reference to prevailing market rates. The payment terms for such transactions are comparable to those offered to unrelated suppliers, 90 days after monthly closing.

C. Lease

(a) Interest expense

	For the year ended December 31,
	2025 2024
Related parties	(NT\$'000)	(NT\$'000)
Parent company	\$52	\$481

(b) Rent expense

		For the year ended December 31,
		2025	2024
Related parties	Nature	(NT\$'000)	(NT\$'000)
Parent company	Buildings	\$-	\$34

(c) Rent income

				For the year ended	December 31,
Related			Method of	2025	2024
parties	Duration	Lease	collection	(NT\$'000)	(NT\$'000)
Parent	2024.04.01~	buildings	Redeemed on the
company	2026.03.31		10th of each month	\$28,642	\$24,115

D. For the years ended December 31, 2025 and 2024, the Group recognized operating expenses of NT\$677 thousand and NT\$4,899 thousand, respectively, for services provided by other related parties.

For the years ended December 31, 2025, the Group recognized operating expenses of NT\$38 thousand for services provided by the associate.

For the years ended December 31, 2025 and 2024, the Group recognized operating expenses of NT\$10,794 thousand and NT641 thousand (tax included), respectively, for services provided by the parent.

For the years ended December 31, 2025and 2024, the Group incurred operating expenses of NT\$20,441 thousand and NT\$45,617 thousand (tax included), respectively, for utility bills paid by the parent on behalf of the Group.

For the years ended December 31, 2025, the Group incurred other income of NT\$100 thousand for provision of services by the parent on behalf on the Group.

For the years ended December 31, 2025, the Group recognized operating revenue of NT\$41 thousand for services provided by other related parties.

E. Accounts receivable - related parties

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Parent company	\$1	\$-
Other related parties	866	-
Less: loss allowance	-	-
Net	\$867	\$-

F. Other receivable - related parties

As of December 31,
2025	2024
(NT\$'000)	(NT\$'000)
\$-	\$7,107

G. Other payables

	As of December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Parent company	\$2,380	\$9,376
Other related parties	1,403	14
Total	\$3,783	\$9,390

H. Guarantee deposits received

As of December 31,
2025	2024
(NT\$'000)	(NT\$'000)
\$3,000	\$3,000

I.Property transection with related party

(a) Acquisition of Assets

			Reference
			basis for price
Variety	Related parties	Acquisition Price	decision
2025.01.01~2025.12.31
Machinery	Parent company	\$1,579	By Bidding
Other equipment	Parent company	\$9,922	By Bidding
Machinery	Other related parties	\$32,197	By Bidding

			Reference basis for price
Variety	Related parties	Acquisition Price	decision
2024.01.01~2024.12.31
Machinery	Parent company	\$7,483	By Bidding
Machinery	Other related parties	\$88,021	By Bidding

• J. On September 21, 2023, the Company's board of directors resolved to purchase Land and Buildings from the related party. Pegatron Corporation, and the total transaction amounted to NT\$3,040,000 thousand (exclude business tax). In March 2024, Land and Buildings transfer have been completed.
• K. Salaries and rewards to key management of the Group

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Short-term employee benefit	\$34,828	\$66,465
Post-employee benefit	791	864
Total	\$35,619	\$67,329

8. PLEDGED ASSETS

The following assets of the Group are pledged as collaterals:

	Carrying Amount As of
	2025	2024
Item	(NT\$'000)	(NT\$'000)	Purpose
Property, plant and equipment - land (carrying amount)	\$196,960	\$196,960	Long-term secured loans
Property, plant and equipment - buildings (carrying amount)	147,809	112,677	Long-term secured loans
Refundable deposits	2,000	2,000	Security deposit to custom authority
Financial assets measured at amortized cost	1,197	-	Performance Bond
Total	\$347,966	\$311,637

9. SIGNIFICANT CONTINGENCIES AND UNRECOGNIZED CONTRACT COMMITMENTS

(1) The Group's unused letters of credit (LC) as of December 31, 2025 are as follows:

Currency		LC Amount (in thousand)	Security (in thousand)
JPY	JPY	\$271,830	\$-
USD	USD	908	-
EUR	EUR	294,405	-

(2) Details of significant constructions in progress and outstanding contracts of property, plant and equipment as of December 31, 2025 are as follows:

			Outstanding
	Contract Amount	Amount Paid	Balance
Nature of Contract	(NT\$'000)	(NT\$'000)	(NT\$'000)
Machinery and
construction contracts	\$10,825,304	\$8,863,120	\$1,962,184
Buildings and machinery	96,950	29,085	67,865
Total	\$10,922,254	\$8,892,205	\$2,030,049

Amount paid above was recognized as construction in progress, equipment awaiting inspection and prepayment for acquiring machinery.

• (3) The Group has entered into a long-term sales agreement with its customer. The customer should fulfill its obligation of making a certain number of orders as agreed in the agreement and the Group shall provide the products to the customer pursuant to the agreement.
• (4) The Group entered into long-term sales agreements with its customers. According to the agreement, after customers pay the deposit in advance, the Group shall provide the products to the customer pursuant to the agreement.

10. LOSSES DUE TO MAJOR DISASTERS

None.

11. SIGNIFICANT SUBSEQUENT EVENT

None.

12. OTHERS

(1) Categories of financial instruments (including disposal groups held for sale)

Financial assets

	As of	December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Financial assets at fair value through profit or loss:
Mandatorily measured at fair value through P/L	\$1,410,294	\$1,121,378
Financial assets at fair value through OCI	52,727	51,000
Financial assets measured at amortized cost (Note)	21,863,336	21,864,829
Total	\$23,326,357	\$23,037,207

Financial liabilities

	As of	December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Financial liabilities at amortized cost:
Short-term borrowings	\$3,053,498	\$3,342,514
Trade and other payables	10,030,261	8,083,421
Long-term borrowings (including current portion
with maturity less than 1 year)	15,394,882	16,795,738
Lease liabilities (including current portion with	115,949	105,119
maturity less than 1 year)
Total	\$28,594,590	\$28,326,792

Note: Financial assets measured at amortized cost include cash and cash equivalents, financial assets measured at amortized cost, notes receivable, accounts receivable (including related parties) and other receivables (including related parties).

(2) Objectives and policies of financial risk management

The Group's principal financial risk management objective is to manage the market risk, credit risk and liquidity risk related to its operating activates. The Group identifies, measures, and manages the risks based on its policy and risk preferences.

The Group has established appropriate policies, procedures and internal controls for financial risk management. Before entering into significant transactions, due approval process by the Board of Directors and Audit Committee must be carried out based on related protocols and internal control procedures. The Group complies with its financial risk management policies always.

(3) Market risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of the changes in market prices. Market risk comprises currency risk, interest rate risk and other price risk (e.g. equity instruments).

In practice, it is rarely the case that a single risk variable will change independently from other risk variables. There are usually interdependencies between risk variables. However, the sensitivity analysis disclosed below does not take into account the interdependencies between risk variables.

Foreign currency risk

The Group's exposure to foreign currency risk relates primarily to the Group's operating activities (when revenue or expense are denominated in a different currency from the Group's functional currency) and the Group's net investments in foreign operations.

The Group has certain foreign currency receivables denominated in the same foreign currency as certain foreign currency payables, therefore natural hedge is achieved. Thus, hedge accounting is not adopted.

Foreign currency sensitivity analysis of possible change in foreign exchange rates on the Group's profit/loss and equity is performed on significant monetary items denominated in foreign currencies as of the reporting period-end. The Group's foreign currency risk is mainly related to volatility in the exchange rates of US dollars. It is stated as follows:

If NT dollars appreciates/depreciates against US dollars by 1%, net income (loss) for the year ended December 31, 2025 and 2024 would increase/decrease by NT\$11,099 thousand and NT\$10,505 thousand, respectively.

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Group's exposure to interest rate risk relates primarily to the Group's investments with variable interest rates and loans with fixed and variable interest rates, which are all categorized as loans and receivables.

The interest rate sensitivity analysis is performed on items exposed to interest rate risk as of the end of the reporting period and presumed to be held for one accounting year, including investments and loans with variable interest rates. If interest rate increases/decreases by 0.1%, the net income (loss) for the year ended December 31, 2025 and 2024 would decrease/increase by NT\$14,972 thousand and NT\$16,220 thousand, respectively.

Equity price risk

The fair value of the Group's unlisted equity securities to market price risk arising from uncertainties about future values of the investment securities. The Group's unlisted equity securities measured at fair value through other comprehensive income. The Group manages the equity price risk through diversification and placing limits on individual and total equity instruments. Reports on the equity portfolio are submitted to the Group's senior management on a regular basis. The Group's Board of Directors reviews and approves all equity investment decisions.

Please refer to Note 12(8) for sensitivity analysis information of other equity instruments or derivatives that are linked to such equity instruments whose fair value measurement is categorized under Level 3.

(4) Credit risk management

Credit risk is the risk that counterparty will not meet its obligations under a contract and result in a financial loss. The Group is exposed to credit risk from operating activities (primarily for accounts and notes receivable) and from its financing activities including bank deposits and other financial instruments.

Customer credit risk is managed by each business unit subject to the Group's established policy, procedures and control relating to customer credit risk management. Credit risk of all customers are assessed based on a comprehensive review of the customers' financial status, credit ratings from credit institutions, past transactions, current economic conditions and the Group's internal credit ratings. The Group also employs some credit enhancement instruments (e.g. prepayment or insurance) to reduce certain counterparty's credit risk.

As of December 31, 2025 and 2024, receivables from the top ten customers accounted for 58.54% and 54.97% of the Group's total accounts receivable, respectively. The concentration of credit risk is relatively insignificant for the remaining receivables.

Credit risk from balances with banks and other financial instruments is managed by the Group's finance division in accordance with the Group's policy. The counterparties that the Group transacts with are determined by internal control procedures. They are banks with fine credit ratings and financial institutions, corporate and government agencies with investmentgrade credit ratings. Thus, there is no significant default risk. Conclusively, no significant credit risk is expected by the Group.

The Group adopted IFRS 9 to assess the expected credit losses. Except for trade receivables, the remaining debt instrument investments which are not measured at fair value through profit or loss, low credit risk for these investments is a prerequisite upon acquisition and by using their credit risk as a basis for the distinction of categories. The Group makes an assessment at each reporting date as to whether the credit risk still meets the conditions of low credit risk and then further determines the method of measuring the loss allowance and the loss ratio.

Financial assets are written off when there is no realistic prospect of future recovery (the issuer or the debtor is in financial difficulties or bankruptcy).

(5) Liquidity risk management

The Group maintains financial flexibility using cash and cash equivalents, highly-liquid marketable securities, bank loans, etc. The table below summarizes the maturity profile of the Group's financial liabilities based on the contractual undiscounted payments and contractual maturity. The payment amount includes the contractual interest. The undiscounted interest payment relating to borrowings with variable interest rates is extrapolated based on the estimated yield curve as of the end of the reporting period.

Non-derivative financial instruments (including disposal groups held for sale)

	Less than					More than 5
	1 year	1 to 2 years	2 to 3 years	3 to 4 years	4 to 5 years	years	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
As of December 31, 2025
Loans	\$7,523,270	\$3,703,680	\$3,500,801	\$2,556,759	\$993,525	\$910,010	\$19,188,045
Payables	10,030,261	-	-	-	-	-	10,030,261
Lease liabilities	39,599	31,617	24,202	15,263	7,474	1,011	119,166
As of December 31, 2024
Loans	\$6,630,906	\$4,120,123	\$3,255,781	\$3,083,400	\$2,162,873	\$1,753,115	\$21,006,198
Payables	7,517,353	-	-	-	-	-	7,517,353
Lease liabilities	32,818	26,652	19,037	13,912	9,065	6,861	108,345

(6) Movement schedule of liabilities arising from financing activities

Movement schedule of liabilities for year ended December 31, 2025:

	Short-term	Long-term	Refundable	Leases	Total liabilities from
	borrowings	borrowings	deposits	liabilities	financing activities
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
As of January 1, 2025	\$2,451,503	\$16,795,738	\$5,433,639	\$105,119	\$24,785,999
Reclassification	891,011	-	30,734	-	921,745
Cash flows	(289,016)	(1,431,156)	(451,736)	(41,913)	(2,213,821)
Non-cash changes
Lease range changes	-	-	-	52,164	52,164

English Translation of Consolidated Financial Statements and Footnotes Originally Issued in Chinese Kinsus Interconnect Technology Corp. Notes to Consolidated Financial Statements (Continued)

Interests on lease liabilities	-	-	-	1,762	1,762
Other	-	30,838	-	-	30,838
Currency rate change	-	(538)	-	(1,183)	(1,721)
As of December 31, 2025	\$3,053,498	\$15,394,882	\$5,012,637	\$115,949	\$23,576,966

Movement schedule of liabilities for the year ended December 31, 2024:

	Short-term Long-term Refundable			Leases	Total liabilities from
	borrowings	borrowings	deposits	liabilities	financing activities
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
As of January 1, 2024	\$1,408,619	\$17,077,722	\$5,153,971	\$273,320	\$23,913,632
Cash flows	1,933,895	(310,272)	310,402	(66,298)	1,867,727
Non-cash changes
Lease range changes	-	-	-	(105,565)	(105,565)
Interests on lease liabilities	-	-	-	1,976	1,976
Other	-	28,288	-	-	28,288
Currency rate change	-	-	-	1,686	1,686
Reclassification to groups				-
held for sale	(891,011)	-	(30,734)		(921,745)
As of December 31, 2024	\$2,451,503	\$16,795,738	\$5,433,639	\$105,119	\$24,785,999

• (7) Fair values of financial instruments
• A. The evaluation methods and assumptions applied in determining the fair value

Fair value is the price that would be received to sell a financial asset or paid to transfer a financial liability in an orderly transaction between willing market participants (not under coercion or liquidation). The following methods and assumptions are used by the Group in estimating the fair values of financial assets and liabilities:

• (a) The carrying amount of cash and cash equivalents, receivables, payables and other current liabilities approximate their fair value due to their short maturity terms.

• (b) For financial assets and liabilities traded in an active market with standard terms and conditions, their fair value is determined based on market quotation price (e.g. listed equity securities, beneficiary certificates, bonds and futures etc.) at the report date.

• (c) Fair value of equity instruments without market quotations (including private placement of listed equity securities, unquoted public company and private company equity securities) are estimated using the market method valuation techniques based on parameters such as prices based on market transactions of equity instruments of identical or comparable entities and other relevant information (for example, inputs such as discount for lack of marketability, P/E ratio of similar entities and Price-Book ratio of similar entities).

• (d) Fair value of debt instruments without market quotations, bank loans, bonds payable and other non-current liabilities are determined based on the counterparty prices or valuation method. The valuation method uses DCF method as a basis, and the assumptions such as the interest rate and discount rate are primarily based on relevant information of similar instrument (such as yield curves published by the Taipei Exchange, average prices for Fixed Rate Commercial Paper published by Reuters and credit risk, etc.)
• B. Fair value of financial instruments measured at amortized cost

The carrying amount of the Group's financial assets and liabilities measure at amortized cost approximates their fair value.

C. Fair value measurement hierarchy for financial instruments

Please refer to Note 12(8) for fair value measurement hierarchy for financial instruments of the Group.

• (8) Fair value measurement hierarchy
• A. Fair value measurement hierarchy

All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy, based on the lowest level input that is significant to the fair value measurement as a whole. Level 1, 2 and 3 inputs are described as follows:

Level 1 – Quoted (unadjusted) market prices in active markets for identical assets or liabilities that the entity can access at the measurement date

• Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly
• Level 3 Unobservable inputs for the asset or liability

For assets and liabilities that are recognized in the financial statements on a recurring basis, the Group determines whether transfers have occurred between Levels in the hierarchy by re-assessing categorization at the end of each reporting period.

B. Fair value measurement hierarchy of the Group's assets and liabilities

The Group does not have assets that are measured at fair value on a non-recurring basis. Fair value measurement hierarchy of the Group's assets and liabilities measured at fair value on a recurring basis is as follows:

As of December 31, 2025

	Level 1	Level 2	Level 3	Total
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Financial assets:
Financial assets at fair value through
profit or loss
Funds	\$1,410,294	\$-	\$-	\$ 1,410,294
Financial assets at fair value through
other comprehensive income
Equity instrument measured at	-	-	52,727	52,727
fair value through other
comprehensive income

Financial liabilities:

None

As of December 31, 2024

	Level 1 (NT\$'000)	Level 2 (NT\$'000)	Level 3 (NT\$'000)	Total (NT\$'000)
Financial assets:
Financial assets at fair value through
profit or loss
Funds	\$1,121,378	\$-	\$-	\$ 1,121,378
Financial assets at fair value through
other comprehensive income
Equity instrument measured at	-	-	51,000	51,000
fair value through other
comprehensive income
Financial liabilities:

None

Transfers between Level 1 and Level 2 during the period

For the year ended December 31, 2025 and 2024, there were no transfers between Level 1 and Level 2 fair value hierarchy.

Reconciliation for fair value measurements on a recurring basis in Level 3 hierarchy

Reconciliation for fair value measurements in Level 3 of the fair value hierarchy for movements during the period is as follows:

	Assets
	Financial assets at fair
	value through other
	comprehensive income
	Stocks
Beginning balances as of January 1, 2025	\$51,000
Acquisition	67,830
Total gains and losses recognized for the year ended December 31, 2025:
Amount recognized in OCI (presented in "Unrealized gains (losses)
from equity instruments investments measured at fair value
through other comprehensive income'')	(66,103)
Ending balances as of December 31, 2025	\$52,727

	Assets
	Financial assets at fair
	value through other
	comprehensive income
	Stocks
Beginning balances as of January 1, 2024	\$51,000
Total gains and losses recognized for the year ended December 31, 2024:
Amount recognized in OCI (presented in "Unrealized gains (losses)
from equity instruments investments measured at fair value
through other comprehensive income'')	-
Ending balances as of December 31, 2024	\$51,000

Information on significant unobservable inputs to valuation

Description of significant unobservable inputs to valuation of recurring fair value measurements categorized within Level 3 of the fair value hierarchy is as follows:

As of December 31, 2025

		Significant		Relationship
	Valuation	unobservable	Quantitative	between inputs and	Sensitivity of the input to
	techniques	inputs	information	fair value	fair value
Financial assets at fair value
through other comprehensive
income
Stocks	Comparable	Discount for	20%	The higher the	5% increase (decrease) in
	listed OTC	lack of		discount for lack of	the discount for lack of
	company law	marketability		marketability, the	marketability would result
				lower the fair value	in decrease/increase in the
				of the stocks	Group's equity by
					NT\$2,373 thousand

As of December 31, 2024

		Significant		Relationship
	Valuation	unobservable	Quantitative	between inputs and	Sensitivity of the input to
	techniques	inputs	information	fair value	fair value
Financial assets at fair value
through other comprehensive
income
Stocks	Comparable	Discount for	20%	The higher the	5% increase (decrease) in
	listed OTC	lack of		discount for lack of	the discount for lack of
	company law	marketability		marketability, the	marketability would result
				lower the fair value	in decrease/increase in the
				of the stocks	Group's equity by
					NT\$2,295 thousand

(9) Significant financial assets and liabilities denominated in foreign currencies

Information regarding the Group's significant financial assets and liabilities denominated in foreign currencies (including disposal groups held for sale) was listed below: (In Thousands)

			As of	December 31,
		2025			2024
	Foreign			Foreign
	Currencies	Exchange	NTD	Currencies	Exchange	NTD
	(\$'000)	Rate	(NT\$'000)	(\$'000)	Rate	(NT\$'000)
Financial assets
Monetary items:
USD	\$376,597	31.4205	\$11,832,860	\$397,531	32.6584	\$12,982,751
CNY	\$154,312	4.4710	\$689,929	\$88,203	4.5615	\$402,340
Financial liabilities
Monetary items:
USD	\$341,268	31.4208	\$10,722,923	\$365,154	32.2277	\$11,932,236
CNY	\$254,347	4.4703	\$1,136,997	\$196,355	4.5615	\$895,675

The above information is disclosed based on the carrying amount of foreign currency (after being converted to functional currency).

Foreign exchange gain/loss on monetary financial assets and liabilities is shown as below.

	For	the year ended December 31,
Foreign currency	2025	2024
resulting in exchange gain or loss	(NT\$'000)	(NT\$'000)
USD	\$32,739	\$64,840
Other	5,725	18,182

(10) Capital management

The primary objective of the Group's capital management is to ensure that it maintains a strong credit rating and healthy capital ratios to support its business and maximize shareholder value. The Group manages and adjusts its capital structure considering changes in economic conditions. To maintain or adjust the capital structure, the Group may adjust dividend payment to shareholders, return capital to shareholders or issue new shares.

13. ADDITIONAL DISCLOSURES

• (1) Information on significant transactions
• A. Financing provided to others: None.
• B. Endorsement/Guarantee provided to others: None.
• C. Marketable securities held as of December 31, 2025 (excluding investments in subsidiaries, associates and joint ventures): Please refer to attachment 1.
• D. Related party transactions with purchase or sales amount of at least NT\$100 million or 20 percent of the paid-in capital for the year ended December 31, 2025: Please refer to attachment 2.

• E. Receivables from related parties of at least NT\$100 million or 20 percent of the paid-in capital as of December 31, 2025: None.

• F. Inter Group relationships and significant inter Group transactions for the year ended December 31, 2025: Please refer to attachment 7.

• (2) Information on investees
• A. Name, locations and related information of investees (excluding investees in Mainland China): Please refer to attachment 3.
• B. Investees over which the Company exercises control shall be disclosed of information under Note 13(1):
  • (a) Financing provided to others: None.
  • (b) Endorsement/Guarantee provided to others: None.
  • (c) Marketable securities held as of December 31, 2025 (excluding investments in subsidiaries, associates and joint ventures): Please refer to attachment 4.
  • (d)Related party transactions with purchase or sales amount of at least NT\$100 million or 20 percent of the paid-in capital for the year ended December 31, 2025: Please refer to attachment 5.
  • (e) Receivables from related parties of at least NT\$100 million or 20 percent of the paidin capital as of December 31, 2025: Please refer to attachment 6.

English Translation of Consolidated Financial Statements and Footnotes Originally Issued in Chinese Kinsus Interconnect Technology Corp. Notes to Consolidated Financial Statements (Continued)

(3) Information on investments in Mainland China:

A. Name of investee in China, main business, paid-in capital, method of investment, investment flows, percentage of ownership, investment gain or loss, carrying amount at the end of reporting period, inward remittance of earning or loss and the upper limit on investment in China:

(In Thousands of New Taiwan Dollars/ Foreign currencies)

Name of Investee in China	Main Business	Paid-in Capital (NT\$'000)	Method of Investment (Note 1)	Accumulated Outflow of Investment from Taiwan as of Jan. 1, 2025 (NT\$'000)	Outflow (NT\$'000)	Investment Flows Inflow (NT\$'000)	Accumulated Outflow of Investment from Taiwan as of Dec. 31, 2025 (NT\$'000)	Profit/ Loss of Investee (NT\$'000)	Percentage of Ownership (Direct or Indirect Investment)	Share of Profit/Loss (NT\$'000)	Carrying Amount as of Dec. 31, 2025 (NT\$'000)	Accumulated Inward Remittance of Earnings as of Dec. 31, 2025 (NT\$'000)	Accumulated Outflow of Investment from Taiwan to Mainland China as of Dec. 31, 2025	Investment Amounts Authorized by Investment Commission, MOEA (NT\$'000)	Upper Limit on Investment in China by Investment Commission, MOEA (NT\$'000)
Kinsus Interconnect Technology Suzhou Corp.	Manufacturing and selling PCB (not high density fine line)	\$2,199,435 (Note 2)	(2)	\$2,199,435 (Note 2)	\$-	\$-	\$2,199,435 (Note 2)	\$72,305 (Note 2 and Note 4)	100%	\$72,305 (Note 2, Note 4)	\$2,024,075 (Note 2, Note 4)	\$966,960	(NT\$'000) \$1,237,968 (Note 2)	\$1,237,968 (Note 2)	No upper limit (Note 5)

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

						Investment Flows							Accumulated
Name of Investee in China	Main Business	Paid-in Capital (NT\$'000)	Method of Investment (Note 1)	Accumulated Outflow of Investment from Taiwan as of Jan. 1, 2025 (NT\$'000)	Outflow (NT\$'000)	Inflow (NT\$'000)	Accumulated Outflow of Investment from Taiwan as of Dec. 31, 2025 (NT\$'000)	Profit/ Loss of Investee (NT\$'000)	Percentage of Ownership (Direct or Indirect Investment)	Share of Profit/Loss (NT\$'000)	Carrying Amount as of Dec. 31, 2025 (NT\$'000)	Accumulated Inward Remittance of Earnings as of Dec. 31, 2025 (NT\$'000)	Outflow of Investment from Taiwan to Mainland China as of Dec. 31, 2025 (NT\$'000)	Investment Amounts Authorized by Investment Commission, MOEA (NT\$'000)	Upper Limit on Investment in China by Investment Commission, MOEA (NT\$'000)
Piotek Computer (Suzhou) Co., Ltd.	Researching, developing, producing and selling electronic components, PCBs and related products and providing after sale services	\$2,221,429 (Note 2)	(3) (Note 10)	\$2,961,499 (Note 2)	\$-	\$-	\$2,961,499 (Note 2)	\$(98,940) (Note 2 and Note 4)	51%	\$(50,459) (Note 2, Note 4)	\$321,298 (Note 2, Note 4)	\$-	\$2,961,499 (Note 2)	\$2,961,499 (Note 2)	No upper limit (Note 5)

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

Name of Investee in China	Main Business	Paid-in Capital (NT\$'000)	Method of Investment (Note 1)	Accumulated Outflow of Investment from Taiwan as of Jan. 1, 2025 (NT\$'000)	Investment Flows Outflow (NT\$'000)	Inflow (NT\$'000)	Accumulated Outflow of Investment from Taiwan as of Dec. 31, 2025 (NT\$'000)	Profit/ Loss of Investee (NT\$'000)	Percentage of Ownership (Direct or Indirect Investment)	Share of Profit/Loss (NT\$'000)	Carrying Amount as of Dec. 31, 2025 (NT\$'000)	Accumulated Inward Remittance of Earnings as of Dec. 31, 2025 (NT\$'000)	Accumulated Outflow of Investment from Taiwan to Mainland China as of Dec. 31, 2025 (NT\$'000)	Investment Amounts Authorized by Investment Commission, MOEA (NT\$'000)	Upper Limit on Investment in China by Investment Commission, MOEA (NT\$'000)
Pegavision (Jiangsu) Limited	Producing and Selling medical equipment	\$194,610 (USD 5,000)	(1)	\$150,150	\$44,460	\$-	\$194,610	\$(37,190) (Note 2 and Note 4)	29.55%	\$(10,990) (Note 2, Note 4 and Note 11)	\$35,112 (Note 2, Note 4 and Note 11)	\$-	\$194,610	\$194,610	\$7,041,517 (Note 6)
BeautyTech Platform (Shanghai) Corporation Pegavision (Shanghai)	Selling medical equipment and cosmetic products Selling medical equipment	\$127,444 (USD 4,100) (Note 13)	(3) (Note 3) (3) (Note 7)	\$14,885 \$95,043	\$- (Note 13) \$-	\$- (Note 13)	\$109,928 \$-	\$16,646 (Note 2 and Note 4) \$(887) (Note 2 and	29.55% 29.55%	\$4,181 (Note 2, Note 4 and Note 11) \$(233) (Note 2, Note 4	\$49,234 (Note 2, Note 4 and Note 11) \$- (Note 2, Note 4	\$- \$-	\$109,928	\$109,928	\$342,152 (Note 9)
Limited								Note 4)		and Note 11)	and Note 11)

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

Name of Investee in China	Main Business	Paid-in Capital (NT\$'000)	Method of Investment (Note 1)	Accumulated Outflow of Investment from Taiwan as of Jan. 1, 2025 (NT\$'000)	Outflow (NT\$'000)	Investment Flows Inflow (NT\$'000)	Accumulated Outflow of Investment from Taiwan as of Dec. 31, 2025 (NT\$'000)	Profit/ Loss of Investee (NT\$'000)	Percentage of Ownership (Direct or Indirect Investment)	Share of Profit/Loss (NT\$'000)	Carrying Amount as of Dec. 31, 2025 (NT\$'000)	Accumulated Inward Remittance of Earnings as of Dec. 31, 2025 (NT\$'000)	Accumulated Outflow of Investment from Taiwan to Mainland China as of Dec. 31, 2025 (NT\$'000)	Investment Amounts Authorized by Investment Commission, MOEA (NT\$'000)	Upper Limit on Investment in China by Investment Commission, MOEA (NT\$'000)
Gemvision Technology (Zhejiang) Limited	Selling medical equipment and cosmetic products	\$98,346 (RMB 22,000) (Note 2)	(3) (Note 8)	\$-	\$-	\$-	\$-	\$5,604 (Note 2 and Note 4)	29.55%	\$1,408 (Note 2, Note 4 and Note 11)	\$34,834 (Note 2, Note 4 and Note 11)	\$-	\$-	\$-	\$342,152 (Note 9)

Note 1: The investment methods are divided into the following three types, just indicate the types:

• (1) Go directly to the mainland for investment.
• (2) Reinvest in mainland China through a third-region company.
• (3) Other methods.

Note 2: Amounts in foreign currencies are translated into New Taiwan dollars using the exchange rates on the balance sheet date.

Note 3: 100% Shares of BeautyTech Platform (Shanghai) owned and directly invested by BeautyTech Platform Corporation.

Note 4: Gain/loss on investment is recognized based on the financial statements which were audited by the independent auditors of the parent company in Taiwan.

Kinsus Interconnect Technology Corp.

Notes to Consolidated Financial Statements (Continued)

• Note 5: The Company meets the conditions of corporate operation headquarters in the Principle of Evaluation for Investment and Technical Cooperation in Mainland China. Thus, there is no upper limit on investment amount.
• Note 6: The upper limit on investment for Pegavision (Jiangsu) Limited is calculated as 60% of the net value of the recent financial statements audited by independent auditors of Pagavision Corporation.
• Note 7: To improve the synergy of the Group, the equity of Pegavision Contact Lenses (Shanghai) Corporation was transferred to BeautyTech Platform Corporation from Pagavision Corporation.
• Note 8: 100% Shares of Gemvision Technology owned and directly invested by Pegavision Contact Lenses (Shanghai) Corporation.
• Note 9: The upper limit on investment for BeautyTech Platform (Shanghai) Corporation, Pegavision (Shanghai) Limited and Gemvision Technology (Zhejiang) Limited are calculated as 60% of the net value of the recent financial statements audited by independent auditors of BeautyTech Platform Corporation.
• Note 10: Please refer to Note 4 (3) for details.
• Note 11: Transactions were eliminated upon preparation of consolidated financial statements.
• Note 12: As of December 31, 2025, the following investments in investee companies in Mainland China had not yet been remitted: (a)FacialBeau (Jiangsu) Corporation which is 100% held by FacialBeau International Corporation was registratered on February 25, 2022. (b)Pegavision (Shaghai) Limited which is 100% held by the Company was registered on April 23,2024.
• Note 13: As part of the Group's business reorganization, BeautyTech Platform (Shanghai) Corporation has merged with Pegavision (Shanghai) Limited in 2025. BeautyTech Platform (Shanghai) Corporation is the surviving entity, and Pegavision (Shanghai) Limited was dissolved upon the completion of the merger.

B. Significant transactions with investees in China:

The significant inter-company transactions with the subsidiary in Mainland China, which were eliminated in the preparation of consolidated financial statements, please refer to attachment 7 for details.

14. OPERATING SEGMENT

• (1)For management purposes, the Group is organized into operating segments based on different products and services and has three reportable operating segments as follows:
• IC Substrate: This segment produces and manufactures BGA substrates and sells the products to manufacturers of electronic products.

Optics: This segment produces, manufactures and sells contact lens.

No operating segments have been aggregated to form the above reportable operating segments.

The Group's operating segments adopts the same accounting policies as those stated in Note 4. Management monitors the operating results of its business units separately for decisionmaking on resource allocation and performance assessment. Segment performance is evaluated based on operating profit or loss and measured consistently with methods applied to operating profit or loss in the consolidated financial statements.

For the year ended December 31, 2025

	IC Substrate	Optics	Elimination	Consolidated
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Revenue
External customer	\$32,311,845	\$7,039,251	\$-	\$39,351,096
Inter-segment	-	158	(158)	-
Total revenue	\$32,311,845	\$7,039,409	\$(158)	\$39,351,096
Segment profit (loss)	\$1,066,863	\$1,650,465	\$-	\$2,717,328

For the year ended December 31, 2024

	IC Substrate	Optics	Elimination	Consolidated
	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
Revenue
External customer	\$23,718,364	\$6,816,615	\$-	\$30,534,979
Inter-segment	-	-	-	-
Total revenue	\$23,718,364	\$6,816,615	\$-	\$30,534,979
Segment profit (loss)	\$(521,744)	\$1,852,794	\$-	\$1,331,050

Details of assets and liabilities under the Group's operating segments are as follows:

	IC Substrate	Optics	Elimination	Consolidated
Segment assets	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
As of 12/31/2025	\$63,799,109	\$16,174,327	\$(156)	\$79,973,280
As of 12/31/2024	\$64,889,534	\$14,545,763	\$-	\$79,435,297
	IC Substrate	Optics	Elimination	Consolidated
Segment liabilities	(NT\$'000)	(NT\$'000)	(NT\$'000)	(NT\$'000)
As of 12/31/2025	\$34,161,774	\$4,438,465	\$(156)	\$38,600,083
As of 12/31/2024	\$36,069,996	\$3,487,068	\$-	\$39,557,064

(2)Geographical information

Revenues from external customers

	For the year ended December 31,
	2025	2024
	(NT\$'000)	(NT\$'000)
Taiwan	\$10,086,408	\$8,498,809
Other countries	29,264,688	22,036,170
Total	\$39,351,096	\$30,534,979

The revenue information above is based on the location of the customers.

Non-current assets (including disposal groups held for sale)

	As of December 31, 2025 2024 (NT\$'000) (NT\$'000)
	\$47,943,524 \$48,876,730 12 23 2,086,119 2,321,896
Taiwan
U.S.A.
China
Japan	13,252	14,252
Vietnam	611,292	395,629
Nederland	27,343	-
Total	\$50,681,542	\$51,608,530

(3)Information about major customers

Individual customer's sale accounted for at least 10% of consolidated net sale:

	For the year ended December 31,
Name of customers	2025	2024
	(NT\$'000)	(NT\$'000)
Customer A	\$7,676,563	\$3,273,117

Kinsus Interconnect Technology Corp. and Subsidiaries

Marketable Securities Held

As of December 31, 2025

Attachment 1

					As of September 30, 2025
Name of Held Company	Type and Name of Marketable Securities	Relationship with the Issuer	Financial Statement Account	Shares / Units	Carrying Amount	Shareholding %	Fair Value	Note
Kinsus Interconnect	Money market funds:
Technology Corp.	Fubon Chi-Hsiang Money Market Fund	-	Financial assets at fair value through profit or loss	18,222,017	\$300,000	-	\$302,108
	Valuation adjustments of financial				2,108
	assets held for trading
	Total				\$302,108
	Stocks:
	Azalea Vision BV	-	Measured at fair value through other comprehensive income	57,142	\$16,950	2.60%	\$432
	Valuation adjustments				(16,518)
	Total				\$432

(In Thousands of New Taiwan Dollars)

Kinsus Interconnect Technology Corp. and Subsidiaries

Related Party Transactions with Purchase or Sales Amount of At least NT\$ 100 Million or 20% of the Paid-in Capital

For the Year Ended December 31, 2025

Attachment 2

					Transaction Details		Abnormal Transaction		Notes/Accounts Payable or Receivable
		Nature of	Purchase/			Payment/ Collection		Payment/
Company Name	Related Party	Relationship	Sale	Amount	% to Total	Term	Unit Price	Collection Term	Ending Balance	% to Total	Note
Kinsus Interconnect	Kinsus Interconnect	Investee accounted	Purchase	\$4,031,228	25.88%	Payment within 60	Specs of goods	Other vendors also	Accounts payable	22.44%	Note
Technology Corp.	Technology Suzhou Corp.	for using equity method indirectly				days from the end of delivery month	purchased are different from others. Cannot be reasonablely compared.	enjoy payment within 30~90 days from the end of delivery month	\$(868,953)

Note: Transactions are eliminated when preparing the consolidated financial statements.

Kinsus Interconnect Technology Corp. and Subsidiaries

Names, Locations and Related Information of Investees

As of December 31, 2025

Attachment 3

(In Thousands of Foreign Currency / New Taiwan Dollars) Original Investment Amount Balance as of December 31, 2025 Investor Investee Business Location As of December 31, 2024 As of December 31, 2025 Shares % Carrying Value Note Kinsus Interconnect Technology Corp. KINSUS CORP. (USA) CA. U.S.A. USD 500 USD 500 500,000股 100.00% \$98,421 \$7,800 \$7,800 Note 1 Kinsus Interconnect Technology Corp. KINSUS HOLDING (SAMOA) LIMITED Samoa Investing activities USD 109,240 USD 109,240 109,239,940股 100.00% \$2,347,084 \$22,082 \$25,026 Note 1 (Note) Kinsus Interconnect Technology Corp. Kinsus Investment Co., Ltd. Taiwan Investing activities \$1,600,000 \$1,600,000 172,000,000股 100.00% \$3,433,815 \$446,428 \$446,428 Note 1 Kinsus Interconnect Technology Corp. Pegavision Corporation Taiwan Manufacturing medical equipment \$564,210 \$564,210 1,820,034股 2.33% \$271,399 \$1,628,044 \$37,988 Note 1 Kinsus Investment Co., Ltd. Pegavision Corporation Taiwan Manufacturing medical equipment \$252,455 \$252,455 21,233,736股 27.22% \$3,166,318 \$1,628,044 \$443,198 Note 1 Kinsus Investment Co., Ltd. Zhuhe Investment Co., Ltd. Taiwan Investing activities \$30,000 \$30,000 3,000,000股 15.00% \$29,113 \$(3,068) \$(514) Note1 KINSUS HOLDING (SAMOA) LIMITED KINSUS HOLDING (CAYMAN) LIMITED Cayman Islands Investing activities USD 70,000 USD 70,000 70,000,000股 100.00% USD 65,151 USD 2,029 USD 2,029 Note 1 KINSUS HOLDING (SAMOA) LIMITED PIOTEK HOLDINGS LTD. (CAYMAN) Cayman Islands Investing activities USD 40,686 USD 40,686 40,686,220股 51.00% USD 9,639 USD (2,593) USD (1,323) Note 1 PIOTEK HOLDINGS LTD. (CAYMAN) PIOTEK HOLDINGS LIMITED British Virgin Islands Investing activities USD 31,863 USD 31,863 31,862,790股 100.00% USD 18,901 USD (2,593) USD (2,593) Note 1 Pegavision Corporation PEGAVISION JAPAN INC. Japan Selling Medical equipment JPY 9,900 JPY 9,900 198股 100.00% \$211,924 \$54,857 \$54,857 Note 1 Pegavision Corporation Mayin Investment Co., Ltd. Taiwan Investing activities \$246,003 \$246,003 32,277,000股 100.00% \$732,271 \$134,520 \$134,520 Note 1 Pegavision Corporation PEGAVISION VIETNAM COMPANY LIMITED Vietnam Manufacturing and selling of medical equipment \$631,333 \$941,333 - 100.00% \$876,584 \$(18,875) \$(18,875) Note 1 Pegavision Corporation Zhuhe Investment Co., Ltd. Taiwan Investing activities \$20,000 \$20,000 2,000,000股 10.00% \$19,408 \$(3,068) \$(343) Note1 Pegavision Corporation PEGAVISION NETHERLANDS B.V. Nederland Selling Medical equipment - EUR 1,150 - 100.00% \$35,519 \$(6,676) \$(6,676) Note1 Mayin Investment Co., Ltd. BeautyTech Platform Corporation Taiwan Selling medical equipment and cosmetic products \$107,500 \$107,500 8,500,000 股 85.00% \$484,715 \$160,096 \$136,081 Note1 Mayin Investment Co., Ltd. FacialBeau International Corporation Taiwan Selling medical equipment and cosmetic products \$27,500 \$27,500 2,750,000股 55.00% \$22,563 \$(3,931) \$(2,162) Note1 BeautyTech Platform Corporation Beautytech Platform (Singapore) Pte. Ltd. Singapore Selling medical equipment and cosmetic products USD 200 - - - \$- \$(181) \$(181) Note1 and Note2 BeautyTech Platform Corporation FORIMART Corporation Taiwan Selling medical equipment and cosmetic products \$15,000 \$15,000 1,500,000股 100.00% \$65,152 \$101 \$101 Note1 BeautyTech Platform Corporation BEAUTYTECH PLATFORM (VIETNAM) Vietnam Selling medical equipment and cosmetic products \$6,923 \$6,923 - 70.00% \$3,786 \$(3,714) \$(2,600) Note1 LIMITED LIABILITY COMPANY FacialBeau International Corporation Aquamax Vision Corporation U.S.A. Selling medical equipment and cosmetic products USD 1,100 USD 1,100 11,000,000股 100.00% \$6,436 \$(639) \$(639) Note1 FacialBeau International Corporation RODNA Co., Ltd. Korea Selling medical equipment and cosmetic products KRW 100,000 KRW 100,000 100,000股 100.00% \$1,797 \$(88) \$(88) Note1 FacialBeau International Corporation IKIDO Inc. Japan Selling medical equipment and cosmetic products JPY 9,900 JPY 9,900 198股 100.00% \$1,848 \$(45) \$(45) Note1 Designing substrates, formulating marketing strategy analysis, developing new customers, researching and development new product technology Main Business and Product Net Income (Loss) of the Investee Share of Income (Loss) of the Investee

Note: This includes investment gain accounted for using the equity method of NT\$22,082 thousand, realized benefits of current upstream transactions of NT5,809 thousand, and unrealized benefits of current upstream transactions of NT\$2,865 thousand.

Note 1: Transactions are eliminated when preparing the consolidated financial statements.

Note 2 : BEAUTYTECH PLATFORM (SINGAPORE) PTE. LTD. has completed the cancellation of registration in 2025 due to group business adjustments.

Kinsus Interconnect Technology Corp. and Subsidiaries

Marketable Securities Held (Excluding Investments in Subsidiaries, Associates and Joint Ventures)

As of December 31, 2025

Attachment 4

(In Thousands of New Taiwan Dollars)

		Relationship			As of December 31, 2025				Guarantee, Pledge or Other Restricted Conditions
		with the		Shares	Carrying				Carrying
Name of Held Company	Type and Name of Marketable Securities	Issuer	Financial Statement Account	(Unit)	Amount	%	Fair Value	Shares	Amount	Note
Pegavision Corporation	Money market funds:
	Yuanta De-Li Money Market Fund	-	Financial assets at fair value through profit or loss	1,001,351	\$17,042	-%	\$942,381	-	\$-
	Mega Diamond Money Market Fund	-	Financial assets at fair value through profit or loss	1,366,785	17,700	-%
	FSITC Taiwan Money Market Fund	-	Financial assets at fair value through profit or loss	5,939,069	96,203	-%
	Fubon Money Market Fund	-	Financial assets at fair value through profit or loss	51,608,086	810,000	-%
Mayin Investment Co., Ltd.	Money market funds:
	FSITC Taiwan Money Market Fund	-	Financial assets at fair value through profit or loss	970,261	15,566	-%	\$15,727	-	\$-
BeautyTech Platform Corporation	Money market funds:
	Yuanta De-Li Money Market Fund	-	Financial assets at fair value through profit or loss	502,952	8,360	-%	\$150,078	-	\$-
	Yuanta Wan-Tai Money Market Fund	-	Financial assets at fair value through profit or loss	2,221,592	34,235	-%
	FSITC Taiwan Money Market Fund	-	Financial assets at fair value through profit or loss	6,530,910	105,601	-%
	Valuation adjustments of financial				3,479
	assets held for trading
	Total				\$1,108,186
Kinsus Investment Co., Ltd.	Stocks:
	Ethos Original Co., Ltd.	-	Measured at fair value through other comprehensive income	5,000,000	\$50,000	7.49%	\$50,000	-	\$-
	Li Chang Finery Inc	-	Measured at fair value through other comprehensive income	32,653	1,000	1.01%	1,000	-	-
Pegavision Corporation	Stocks:
	Azalea Vision BV	-	Measured at fair value through other comprehensive income	171,428	50,880	7.79%	1,295	-	-
	Add:Valuation adjustments				(49,585)
	Total				\$52,295		\$52,295		\$-

Kinsus Interconnect Technology Corp. and Subsidiaries

Related Party Transactions with Purchase or Sales Amount of At least NT\$100 Million or 20% of the Paid-in Capital

For the Year Ended December 31, 2025

Attachment 5

(In Thousands of New Taiwan Dollars)

			Transaction Details				Abnormal Transaction
	Related Party		Purchase/ Sale Amount % to Total Payment/ Collection Term Sales USD 130,286 99.94% Payment within 60 days								Note
Kinsus Interconnect Technology Suzhou Corp.	Kinsus Interconnect Technology Corp.	Parent company				from the end of delivery month	Specs of goods sold are different from others. Cannot be reasonably compared.	No non-related parties to be compared with.	Accounts receivable USD 28,526	100.00%	Note
Pegavision Corporation	Pegavision Japan Inc.	Also a subsidiary under the Company's control	Sales	\$4,036,216	66.74%	Payment within 90 days from the end of delivery month	Similar to those to third party customers.	Payment within 90 days from telegraphic transfer.	Accounts receivable \$752,556	64.86%	Note
Pegavision Corporation	BeautyTech Platform Corporation	Also a subsidiary under the Company's control	Sales	\$380,357	6.26%	Payment within 120 days from the end of delivery month	Similar to those to third party customers.	Payment within 90 days from telegraphic transfer.	Accounts receivable \$149,543	12.89%	Note
Pegavision Corporation		Also a subsidiary under the Company's control	Sales	\$104,265	1.72%	Payment within 180 days from the end of delivery month	Similar to those to third party customers.	Payment within 90 days from telegraphic transfer.	Accounts receivable \$13,502	1.16%	Note
	Company Name	Gemvision Technology (Zhejiang) Limited	Nature of Relationship					Unit Price	Payment/ Collection Term	Ending Balance	Notes/Accounts Payable or Receivable % to Total

Note: It is the valuation adjustment related to the financial assets recognized at fair value

Kinsus Interconnect Technology Corp. and Subsidiaries

Receivables from Related Parties of at Least NT\$ 100 Million or 20% of the Paid-in Capital

As of December 31, 2025

Attachment 6

		Nature of			Overdue Turnover		Amount Received in
Company Name	Related Party	Relationship	Ending Balance	Ratio	Amount	Action Taken	Subsequent Periods	Loss Allowance
Kinsus Interconnect	Kinsus Interconnect	Parent company	USD 28,526	5.07	\$-	-	\$-	\$-
Technology Suzhou Corp.	Technology Corp.		(Note)
Pegavision Corporation	Pegavision Japan Inc.	Subsidiary	\$752,556 (Note)	5.64	\$-	-	\$317,467	\$-
Pegavision Corporation	BeautyTech Platform Corporation	Subsidiary	\$149,543 (Note)	2.68	\$-	-	\$28,977	\$-

(In Thousands of Foreign Currency / New Taiwan Dollars)

Note: Transactions are eliminated when preparing the consolidated financial statements.

Kinsus Interconnect Technology Corp. and Subsidiaries

Intercompany Relationships and Significant Intercompany Transactions

For the Year Ended December 31, 2025

Attachment 7

(In Thousands of Foreign Currency / New Taiwan Dollars)

No.				Intercompany Transaction
(Note 1)	Company Name Counter-Party		Nature of Relationship (Note 2)	Financial Statement Account	Amount (Note 4)	Terms	Percentage to Consolidated Net Revenue or Total Assets (Note 3)
0	2025.01.01~2025.12.31 Kinsus Interconnect Technology Corp.	Kinsus Interconnect Technology Suzhou Corp.	1	Accounts payable		\$868,953 Payment within 60 days from the end of delivery month	1.09%
0	Kinsus Interconnect Technology Corp.	Kinsus Interconnect Technology Suzhou Corp.	1	Sales revenue		\$38,077 Payment within 30 days from the end of delivery month	0.10%
0	Kinsus Interconnect Technology Corp.	Kinsus Interconnect Technology Suzhou Corp.	1	Purchase		\$4,031,228 Payment within 60 days from the end of delivery month	10.24%
0	Kinsus Interconnect Technology Corp.	KINSUS CORP. (USA)	1	Commission Expense		\$52,075 Payment within 30 days from the end of delivery month T/T	0.13%
1	Pegavision Corporation	PEGAVISION JAPAN INC.	3	Sales revenue		\$4,036,216 Payment within 90 days from the end of delivery month	10.26%
1	Pegavision Corporation	PEGAVISION JAPAN INC.	3	Accounts receivable		\$752,556 Payment within 90 days from the end of delivery month	0.94%
1	Pegavision Corporation	Gemvision Technology (Jiangsu) Limited	3	Sales revenue		\$35,141 Payment within 180 days from the end of delivery month	0.09%
1	Pegavision Corporation	Gemvision Technology (Jiangsu) Limited	3	Accounts receivable		\$21,065 Payment within 180 days from the end of delivery month	0.03%
1	Pegavision Corporation	BeautyTech Platform Corporation	3	Sales revenue		\$380,357 Payment within 120 days from the end of delivery month	0.97%
1	Pegavision Corporation	BeautyTech Platform Corporation	3	Accounts receivable		\$149,543 Payment within 120 days from the end of delivery month	0.19%
1	Pegavision Corporation	BeautyTech Platform Corporation	3	Operating expense		\$78,731 Payment within 120 days from the end of delivery month	0.20%
1	Pegavision Corporation	Gemvision Technology (Zhejiang) Limited	3	Sales revenue		\$104,265 Payment within 180 days from the end of delivery month	0.26%
1	Pegavision Corporation	Gemvision Technology (Zhejiang) Limited	3	Contract liability		\$103,231 Payment within 180 days from the end of delivery month	0.13%
2	FacialBeau International Corporation	BeautyTech Platform Corporation	3	Other revenue		\$18,800 Payment within 30 days from the end of delivery month	0.05%
3	BeautyTech Platform (Shanghai) Corporation	Gemvision Technology (Zhejiang) Limited	3	Service revenue		\$52,515 Payment within 30 days from the end of delivery month	0.13%

Note 1: Transaction information between Parent company and its subsidiaries should be disclosed by codes below:

(1) Parent company is coded "0".

(2) The subsidiaries are coded from "1" in the order presented in the table above.

Note 2: Relationship are divided into the following three types and the types are required to be indicated:

(1) From the parent company to a subsidiary.

(2) From a subsidiary to the parent company.

(3) Between subsidiaries.

Note 3: Regarding the percentage of transaction amount to consolidated operating revenues or total assets, it is computed based on the ending balance to consolidated total assets for balance sheet items;

and based on interim accumulated amount to consolidated net revenue for income statement items.

Note 4: Transactions exceeding NT\$15,000 thousand have been disclosed. All the transactions have been eliminated when preparing the consolidated financial statements.